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BACKGROUND: Approximately 25% of all cancers diagnosed are considered rare. Patients 
may face many significant challenges including difficulty obtaining information about their rare 
conditions. Patients often have high information needs and may seek desired information from a 
variety of informational sources including healthcare providers, media, print, government and 
non-profit organizations in order to meet their needs. Accessing reliable consumer-level 
information can be challenging and often information needs are unmet. Dissatisfaction with 
health information provision can result in negative health-related outcomes and factors including 
decreased health-related quality of life.   
METHOD: This cross-sectional design study used validated measures to assess the information 
needs, information sources, information satisfaction, and health-related quality of life of patients 
diagnosed with rare cancers (n=113). Adult patients at the VCU Health Massey Cancer Center 
  
 
who had been diagnosed with a rare cancer in the past 12 months were contacted via mail survey.  
Descriptive statistics were used to summarize patients’ information need and information 
received levels.  Unmet needs were analyzed using a two-sample T-test. Chi-square tests were 
used to analyze information needs and received by demographics for gender and race and logistic 
regression analysis was used for age.  Descriptive statistics summarized information sources 
used and preferred.  Finally, descriptive statistics were used to summarize information 
satisfaction. The relationship between information satisfaction and health-related quality of life 
was assessed using a two-sample T-test. 
RESULTS: Study participants had high information needs, particularly for information about 
disease, medical tests, and treatment.  Though patients also reported receiving information at 
high levels, 21 participants (18.9%) reported being unsatisfied with information provision. 
Unmet needs were found for information about disease and on the item level for information 
about causes of cancer, whether their cancer was under control, expected benefits of treatment, 
and financial, insurance, and work-related information. Although participants reported preferring 
information from their healthcare providers, they most commonly sought information from the 
Internet more than any other source. 
CONCLUSION: By identifying patients’ information needs and sources, this study fills an 
important gap in the information needs and sources literature of patients diagnosed with rare 
cancers.  Identification of these needs allows healthcare providers to tailor information provision 
to more effectively meet patients’ information needs.  
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Chapter I. Introduction 
 
 
According to the National Cancer Institute, in 2016 over 1.6 million people will be 
diagnosed with cancer in the United States (National Cancer Institute, 2014).  While there are 
few patients diagnosed with any one type of rare cancer, approximately 25% of all cancers are 
considered rare (Greenlee, Goodman, Lynch, Platz, & Havener, 2010).  
 Patients with rare cancers face many significant challenges in addition to the attendant 
complications of dealing with a potentially life-threatening and life-altering illness (Schaefer, 
2012).  Patients with rare cancers may have difficulty obtaining a correct and timely diagnosis; 
have few or no treatment options; and often lack access to specialists (Schaefer, 2012).  In 
addition, patients with rare cancers often have difficulty accessing and obtaining consumer-level 
information about their types of cancers (Schaefer, 2012). Cancer-related information needs and 
sources of health information have been researched in patients diagnosed with common cancers; 
however, little is known about the unique health information needs (types of cancer information 
sought and desired) and the information sources used and preferred by patients diagnosed with 
rare cancers.  The research found in the literature that examines the information needs and 
information sources of patients diagnosed with a rare disease is often limited to the study of 
parents of children with very rare genetic conditions.   
 A cancer diagnosis in general can have a profound impact on patients, and can result in a 
variety of health information needs throughout the cancer care continuum (Rutten, Arora, Bakos, 
Aziz, & Rowland, 2005).  Many of these patients desire additional information about their 
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diagnosis, treatment options, prognosis, coping, complementary and alternative medicine, 
relapse, legal and financial, and survivorship information.  
Patients with cancer seek information from a variety of sources including healthcare 
providers, media, print, government and non-profit organizations, and others to fulfill their 
information needs.  Most patients, when questioned, prefer to receive health information from 
their healthcare provider; however, many report that they actually sought and received 
information from a variety of other sources (Rutten et al., 2005; Chou, Liu, Post, & Hesse, 
2011).   
 While patients desire and seek information regarding their cancers or rare diseases, often 
information needs are not met.  Unsatisfied information needs can result in a variety of negative 
associated factors as compared to patients who report information satisfaction (Halkett, 
Kristjanson, Lobb, Little, & Shaw, 2012) Decreased trust in physician, decreased satisfaction 
with health care, and a low health-related quality of life can result from patients having unmet or 
unsatisfied information needs (Halkett et al., 2012).  These factors are important to consider as 
they have been found to be associated with cancer patients’ treatment adherence and overall 
survival (Halkett et al., 2012). 
Using a modified version of Johnson’s Comprehensive Model of Cancer Information 
Seeking (Johnson, 1997) as a guide, this cross-sectional survey study examines the unique 
information needs and information sources used and preferred by patients who have been 
diagnosed with rare cancers.  Data were collected using validated and reliable measures via mail 
surveys of patients diagnosed with rare cancers at the Virginia Commonwealth University 
Massey Cancer Center.  In addition, this study examines the association between information 
satisfaction and health-related quality of life.  Overall, this study fills a gap in the rare cancer 
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literature as it provides an understanding of the information needs and information sources of 
patients with rare cancers, an often overlooked and neglected patient population. 
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Chapter II. Literature Review 
 
 
Definition of Rare Cancer   
 Before examining the information needs and information sources of patients diagnosed 
with cancers, it is important first to have an understanding of the definition of rare cancer and the 
various challenges faced by those diagnosed with rare cancers.  Many different definitions of 
rare cancer have been developed by national and international rare disease organizations, but no 
single definition of a rare cancer has been agreed upon.  Defining rare cancer is not easy and any 
definition of a rare cancer is considered artificial (RareCare, 2014).  In general, in the United 
States, a cancer is considered to be rare if it affects fewer than 200,000 people.  This is the 
definition of rare disease used by both the United States Orphan Drug Act and the National 
Institute of Health’s Office of Rare Diseases Research (Office of Rare Disease Research, 2014).  
The Orphan Drug Act states that “rare” may also be defined as a condition affecting more than 
200,000 people but for which drug development will not be recouped from sales of the drug in 
the United States (Eslick, 2012). 
When studying rare cancers, Eslick (2012) explains that it is necessary to understand the 
difference between incidence rate and prevalence rate.  Some rare cancers with a low incidence 
rate and that are highly curable may have a high prevalence rate due to patients living longer 
with the cancer.  Conversely, there are common cancers with very poor survival rates that make 
their disease prevalence low (Gatta, Capocaccia, Trama, & Martinez-Garcia, 2011).   Therefore, 
defining a rare cancer using incidence rate rather than prevalence rate accounts for the varying 
life expectancy among patients with different types of rare cancers (RareCare, 2014).   
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Another consideration related to rare cancers is that they are not only rare histologic 
(primary cancer) variants, but also include: 1) subgroups that are difficult to study in common 
cancers; 2) common cancers or metastasis in uncommon sites; 3) common cancers in uncommon 
hosts; 4) cancers with unusual presenting symptoms, manifestations, or complications; and 5) 
cancers that rarely affect a particular age group or population.  Delay in diagnosis or 
misdiagnoses can occur in these circumstances (Duffy, 2012).   
For example, Miller (2010), describing rare subtypes of common cancers, provides the 
example of adenoid cystic carcinoma of the breast.  While breast cancer is a common form of 
cancer in women, adenoid cystic breast cancer is a rare subtype of breast cancer, affecting only 
about one percent of those with breast cancer (Johns Hopkins Medicine, 2014).  Examples of 
common cancers in rare sites include primary extra-ovarian tumors, inflammatory breast cancer, 
non-carcinoma breast cancers, ductal carcinoma in salivary glands, and non-cutaneous 
melanomas (Duffy, 2012; Greenlee et al., 2010).  
Rare cancers can also be common cancers that present themselves in uncommon hosts 
such as breast cancer occurring in men (Eslick, 2012; Greenlee et al., 2010).  Additionally, some 
literature also includes rare cancers that may have uncommon initial symptoms, making 
diagnosis difficult.  Furthermore, cancers that do not often affect a particular age group, such as 
when a pediatric type of cancer occurs in an adult can be considered rare (Calhoun, 1998).   
There are other factors that should be taken into account when studying rare cancers.  It is 
important to know that some rare cancers do attract more media attention and obtain more 
funding and research than other rare cancers.  An example of this includes malignant 
mesothelioma, a rare type of cancer that often affects the pleural tissue that lines the lungs, but 
can also affect tissue lining of the stomach, heart, and other organs. Many patients who are 
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diagnosed with mesothelioma were occupationally exposed to asbestos.  Mesothelioma has had 
considerable recent media exposure due to the many class-action, wrongful death lawsuits that 
have resulted from workplace exposure and subsequent mesothelioma diagnosis. Often, for these 
types of rare cancers, there is a greater awareness of the cancer and generally more information 
is available for both physicians and patients.   
Individually, rare cancers affect only a very small percentage of people; however, 
collectively, rare cancers account for a large percentage of cancers.  Miller (2010, p. 46) states, 
“Although individual rare diseases may be infrequently encountered, rare diseases in aggregate 
affect tens of millions of individuals in the US, Europe and worldwide.”  Likewise, Greenlee et 
al. (2010) found that 25% of patients with cancers in the United States have a rare cancer.  The 
research team defined “rare” as being fewer than 150 incident cases per one million per year. 
Incidentally, by defining rare cancers as less than 150 per one million, only 11 in the U.S are 
considered common: prostate, breast, lung/bronchus, colon, uterine, bladder, melanoma, rectal, 
ovarian, non-Hodgkin lymphoma, and kidney/renal pelvis cancer (Greenlee et al., 2010). 
Rare cancers are also known as “orphan diseases” as they have been neglected by the 
medical and research community for many years (Eslick, 2012).  Consequently, due to this long-
standing neglect, patients with rare cancers encounter a lack of resources and organizational 
support compared to those diagnosed with more common types of cancers. 
Rare Cancer Challenges 
 Gatta et al. (2011, p. 2494) state, “A major problem with rare cancers is that their overall 
burden on society has not been adequately estimated, although they are thought to constitute a 
major public health problem….Improving the quality of care for these cancers is a public health 
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priority.”  In order to provide a brief overview of the significance of having a rare cancer, 
outlined below are some of the many challenges encountered by patients with rare cancers.  
 In addition to the difficulty of dealing with a cancer diagnosis and its attendant impact on 
the patient’s health, patients diagnosed with rare cancers encounter many challenges due to the 
rarity of their conditions.  While there are many rare cancers, few people have any one specific 
rare cancer. Consequently, rare cancers are often underfunded and understudied compared to 
other more common cancers (“Very Rare Cancers,” 2001). Both epidemiological and natural 
history studies of rare cancers are very difficult to conduct due to lack of funding and few 
patients to participate in studies (Casali, Bruzzi, Bogaerts, & Blay, 2015).  Also contributing to 
the difficulties of conducting rare cancer research is a lack of unique International Classification 
of Disease (ICD) codes for many very rare cancers (Ayme, Bellet, & Rath, 2015).  For example, 
angiofollicular lymph node hyperplasia (Castleman Disease), a very rare lymphoma-like disease, 
lacks its own ICD code and is coded under a more general ICD code, “lymphadenopathy,” along 
with other diseases, making research difficult (Castleman’s Disease Collaborative Network, 
2014).  Additionally, there are fewer available cancer registries and tissue banks for rare cancer 
types than those for more common types of cancers (Schaefer, 2012).   
 Inadequate diagnostics and physicians’ lack of knowledge of specific rare cancers 
(Schaefer, 2012) contribute to late or incorrect diagnoses of rare cancer (Feinberg, Law, Singh, 
& Wright, 2013; Jeffries & Clifford, 2009).  Furthermore, patients may have difficulty finding 
and accessing clinical experts who have the expertise to diagnose the rare cancer. Patients with 
rare cancers may have to seek multiple medical opinions and travel distances to consult qualified 
experts for a complete diagnostic workup in order to obtain an accurate diagnosis.  In a 
qualitative study by Jeffries and Clifford (2009) of women with cancer of the vulva (a rare 
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cancer), women reported the frustration of delayed and incorrect diagnosis.  Many women in the 
study expressed shock over a cancer diagnosis after being assured for years that they had a 
benign condition (Jeffries & Clifford, 2009).  When physicians fail to find a medical diagnosis 
for the patients’ symptoms, patients who repeatedly seek medical opinions for their undiagnosed 
symptoms may be diagnosed as having a psychosomatic or stress-related condition (Jeffries & 
Clifford, 2009). 
 Patients with rare cancers face additional challenges with regard to receiving timely and 
appropriate treatment.  Delayed diagnosis, described above, may also result in treatment delays 
for the patient.  Furthermore, appropriate therapies for the condition may not be available.  There 
is often a lack of interest in drug development among pharmaceutical companies, with a 
limited/small potential market of patients resulting in difficulty recouping costs and few patients 
available to participate in existing clinical trials.  These factors contribute to limited treatment 
options and often no U.S. Food and Drug Administration (FDA) approved therapies for many 
rare cancers.   
 Lack of research and physician knowledge; late and incorrect diagnosis; and insufficient 
treatments have a negative impact on patients. These factors contribute to the survival rate of 
patients with rare cancers being lower than the survival rate of patients with more common 
cancers (Eslick, 2012; Greenlee et al., 2010; Williams, 2011).  As Greenlee et al. (2010, p.41) 
report, very rare cancers “can be rapidly fatal.” 
 In addition to the challenges briefly outlined above, patients with rare cancers experience 
a lack of accessible and reliable information.  Although they desire health information about 
their condition, finding authoritative information about rare cancers can be a daunting challenge 
(Walker, 2013).    
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Furthermore, there is a paucity of research in the literature regarding the health 
information needs and information sources of patients diagnosed with rare cancers.  Even when 
broadening the scope of the search to include information needs of patients with any type of rare 
condition, there is very little written regarding this population.  Most rare disease research has 
been conducted in Europe and focuses on the diagnostic challenges and information needs of 
parents of children who have rare genetic disorders (Bouwman, Teunissen, Wijburg, & Linthorst, 
2010; Tozzi, Mingarelli, Agircola, Gonfiiantine, & Pandolfi, 2013).  In a systematic review of 
research of cancer patients’ information needs and sources for finding information, Rutten et al. 
(2005, p. 258) state, “Future research should address the limitations identified in past research by 
assessing the information needs and sources of large, representative, and diverse samples of 
cancer patients, including those with rare cancer diagnoses.” Since this 2005 article, very little 
has been written to address the gap of patients’ rare cancer information needs in the research 
literature.   
General Cancer Patients’ Information Needs and Information Sources  
Because of the lack of data available on information needs and sources for patients with 
rare cancers, the following examines the types of information sought and sources used by those 
in the general (non-rare) cancer patient population.  
Information needs. Cancer patients’ information needs vary over the cancer care 
continuum (Halkett et al., 2012; Maddock, Lewis, Ahmad, & Sullivan, 2011; Matsuyama, Kuhn, 
Molisani, & Wilson-Genderson, 2013; Rutten et al., 2005).  Cancer information needs are at their 
highest during the diagnosis and treatment phases.  (Maddock et al, 2011; Matsuyama et al., 2013; 
Rutten et al., 2005).   Cancer information needs reduce slightly following treatment, but remain 
high throughout the cancer care continuum. According to Matsuyama et al., 2013, p. 100).  
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“Information needs may be high because many patients have no experience with cancer at the time 
of diagnosis and want information to be able to understand and cope with their cancers. 
Information needs decrease over time indicating that patients are able to obtain and process needed 
information throughout treatment.  However, since their needs for information remain high it 
would appear that new needs arise.”  
The quantity of information desired also varies from patients desiring no information 
about their cancers to those who want to know everything.  In a study of cancer website users, 
researchers found respondents “wanted information on all aspects of cancer (Maddock et al., 
2011).”  In another study, most participants responding to a question about desired information 
stated that they wanted “everything, including bad news” for side effects, disease, and chance of 
getting worse (Matsuyama et al., 2013).   In contrast, Balka, Krueger, Holmes, & Stephen’s 
(2010) study of breast cancer patients’ information needs found that some women did not want 
any additional information about their breast cancer.   
Those patients who desire information have a variety of health information needs. Rutten 
et al. (2005) reported categories of informational needs of patients with cancers based upon a 
systematic review of the cancer information needs literature.  The categories of cancer 
information needs outlined in more detail below are: cancer-specific information; treatment-
related information; prognosis information; surveillance information and health information; 
coping and interpersonal/social information; financial/insurance/legal information; and medical 
system information.   
Cancer-specific information: Cancer-specific information includes information on the 
type of cancer, etiology, physical effects, diagnosis, and symptoms of the patients’ specific 
cancer (Rutten et al., 2005).  A study by Shea-Budgell, Kosarus, Myhill, & Hagan (2014) about 
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information needs of 411 patients with general cancers found that 43% reported searching for 
information on their specific cancer type.  Women in a study of breast cancer information needs 
reported desiring breast cancer information to verify existing knowledge of their condition and to 
elaborate further on what they already know (Balka et al., 2010). 
Treatment-related information: This category encompasses information about the 
patient’s treatment, treatment options (Shea-Budgell et al., 2014), side effects, clinical trials 
(Maddock et al., 2011), and medication information.  Shea-Budgell, et al. (2014) found that the 
majority of patients reported that treatment was the most important type of information.  In 
addition to desiring information about specific treatment options mentioned by the physician, 
patients also desire information about all treatment options available for their conditions 
(Castleton, Fong, Wang-Gillam, Waqar, & Jeffe, 2010).  Cancer patients report searching for 
information about treatment options such as chemotherapy, radiotherapy, and surgery.  Patients 
also desire information about side effects of treatment (Castleton et al., 2010; Chou et al., 2011) 
and information about how to manage the side effect symptoms of treatment (Castleton et al., 
2010; Tustin, 2010). A longitudinal study of the information needs of women receiving 
radiotherapy for breast cancer found that women desire information about treatment side effects 
and the impact of treatment on their overall health and life (Halkett et al., 2012).  Beyond 
standard treatment options, cancer patients search for information about integrative and 
complementary and alternative (CAM) therapy options (Castleton et al., 2010; Rutten et al., 
2005). 
Prognosis information: Patients inquire about their prognosis, recovery, and long-term 
outcomes (Chou et al., 2011; Rutten et al., 2005; Shea-Budgell et al., 2014), with 58% of cancer 
patients reporting they sought information regarding prognosis for their particular types of cancer 
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(Castleton et al., 2010).  In a study by Balka et al. (2010) using narrative to explore the 
information needs of breast cancer patients, many women reported seeking breast cancer health 
information for prognosis and long-term life expectancies.  One respondent in the study stated, “I 
needed to know if I was going to die (Balka et al., 2010, p. 398).” 
Surveillance information and health information: Patients with cancer also seek 
information about their physical and psychological health, prevention, and early detection 
(Rutten et al., 2005).  Maddock et al. (2011) report that patients desire information about leading 
a healthy lifestyle, including diet and nutrition and engaging in physical activity.  Along with 
health information, patients with cancer desire information about sexuality and physical 
appearance (Rutten et al., 2005).  Patients in a study of cancer survivors reported needing 
information about sexual functioning and fertility (Kent, Arora, Rowland, Bellizzi, & Forsythe, 
2012). Other types of health information included in this category are self-care, recovery, and 
post-treatment follow-up care (Rutten et al., 2005).   
Coping information and interpersonal/social information: This category includes 
information about resources for emotional and spiritual support and how to cope with cancer 
(Castleton et al., 2010; Rutten et al., 2005).  Although not reported as highly as other information 
needs, approximately 9% of general cancer patients need psychosocial information.  Patients 
may seek information about support groups and desire to meet others diagnosed with their 
particular type of cancer (Rutten et al., 2005). Maddock et al. (2011) report patients seek 
counseling information and information about support groups that they can join.   Rutten et al. 
(2005) report that patients need information regarding cancer’s effect on family, friends, and 
work and may seek information about how to talk to family members about their cancer. 
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Financial/insurance/legal information: Patients with cancer report financial, insurance, 
and legal information needs (Rutten et al., 2005). Patients may experience significant costs for 
treatment and care not covered by health insurance. Patients, particularly those with rare cancers 
may have to travel to consult disease-specific specialists and receive diagnostic tests and 
appropriate therapies.  Due to illness, patients may also not be able to work or may miss time 
from work for medical appointments. This may cause a huge financial impact, and patients may 
need information about financial and insurance resources.  Patients also report that they need 
legal information, which may include information about wills and advance directives (Maddock 
et al., 2011; Rutten et al., 2005). 
Medical system information: This final category of information needs includes 
information about healthcare providers and specialists, experience and qualifications of 
physicians and healthcare providers, and information about health care systems (Rutten et al., 
2005).  Patients use information sources to assess the credentials of their oncologists and the 
hospitals from which they are receiving healthcare services (Tustin, 2010).  Patients with rare 
cancers may search for cancer-specific specialists. 
The above section describes the types of information that patients with cancer report 
needing and seeking to fill their information gaps. The section below outlines the different types 
of sources which patients want to find information about their cancer and from which they report 
receiving information. 
 Information Sources.  Sources of cancer health information include healthcare 
providers; media (including the Internet); print and libraries; interpersonal; and cancer 
organizations (Balka et al., 2010; Kowalczyk & Draper, 2012; Roach, Lykins, Gochett, 
Brechting, & Graue, 2009; Rutten, 2005; Shea-Budgell et al., 2014; Tustin, 2010). Shea-Budgell 
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et al. (2014) found that the majority of patients trusted their health care provider as a source of 
information compared to all other sources.  However, while patients report that they prefer to 
receive information from their health care providers, they also seek and receive cancer-related 
information from a variety of sources (Chou et al., 2011; Rutten, 2005).  Cancer information 
sources will be outlined and explained in detail below.   
Health care providers: This category encompasses the healthcare team and includes: 
physicians (oncologists, general practitioners, surgeons, and radiologists), nurses, and other 
health care providers. Rutten’s et al. (2005) secondary data analysis of Health Information 
National Trends Survey (HINTS) data found that 27.3% of patients reported receiving health 
information from a health care provider. A study by Shea-Budgell et al. (2014) showed that 
cancer patients rated their doctor or health professional as the most-trusted cancer information 
source over the Internet, family, friends, radio, newspaper, and television.  The patients in the 
study responded that their preferred source of cancer information is meeting in person with a 
health care professional (84%). 
Halkett’s et al. (2012) study of breast cancer patients undergoing radiotherapy found that 
patients in reported that a consultation with a radiation therapist would be beneficial in order to 
receive additional information about radiotherapy.  The authors of this study suggest that patients 
should be provided with additional information before their radiotherapy appointment. 
Media: This category includes the Internet, television, videos, and radio. Rutten et al, 
(2005) found that 13.5% report the use of media and 37.1% of those reporting use of media 
report the use of the Internet to obtain cancer-related health information. A 2003 HINTS 
secondary data analysis found that 38% of cancer patients reported seeking information from the 
Internet, more than any other source (Roach et al., 2009).   Another secondary data analysis of 
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HINTS 2007 data estimated percentages of respondents’ first choices for accessing cancer health 
information and found that 25% responded that the Internet is their first choice (Kowalczyk & 
Draper, 2012). Patients reported searching for health information online and using the Internet to 
participate in online support groups, read health-related blogs, and email health care providers 
for information (Chou et al., 2011). 
   In contrast to high Internet use, Roach et al. (2009) found only 2% of patients with 
cancer reported using broadcast media (television, video) to search for health information.  
Likewise, in a study of breast cancer patients, Balka et al. (2009) found that patients rarely report 
watching videos to learn more about cancer.   
Print: Books, magazines, newspapers, brochures, handouts, and libraries encompass print 
sources of health information.  Rutten et al. (2005) report that 26.2% of patients use print 
materials for finding cancer health-related information. Additionally, patients also report using 
the library as a source of information about their cancers (Kowalzyk et al., 2012; Rutten et al., 
2005).  
Interpersonal: Sources of interpersonal communication include patients talking to 
friends, family, co-workers, clergy, and other patients. Cancer patients report using interpersonal 
communication (19%) as a source of health information (Maddock et al., 2011; Rutten et al., 
2005).  Of those who use interpersonal communication, 43% report communicating with friends 
and family, 31% report using support groups, 20% report seeking information from other 
patients, and 6% report that their clergy or church is a source of information (Rutten et al., 2005).  
Methods of interpersonal communication, for communicating with fellow patients, are through 
online, telephone, and in-person support groups (Rutten et al., 2005).   
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Organizations: According to Rutten et al. (2005), this category of information sources 
encompasses telephone information services, charitable and professional organizations, and 
health care organizations.  In addition to raising awareness of general or specific cancers, 
organizations provide advocacy, lobbying, research, collaboration, funding, support, and 
education (Newlands, 2012).  An example of a cancer organization is the American Cancer 
Society.  Many of the organizations have online webpages that patients can use to access 
information and also telephone hotlines for information. Most cancer organizations also provide 
access to disease-specific online support groups (Ayme, Bellet, & Rath, 2008). These 
organizations may also publish journals with articles and information about cancer. 
Information Satisfaction 
 
 The American Society of Clinical Oncology (ASCO) and the European Society for 
Medical Oncology (ESM) developed the Consensus Statement on Quality Care, a ten-point 
statement to ensure quality of cancer care.  The first goal of the consensus statement is, “Access 
to information.” (The American Society of Clinical Oncology, 2006).  The access to information 
goal states, “Patients should receive adequate information about their illness, possible 
interventions, and the known benefits and risks of specific treatment options.”      
 The above sections provided an overview of cancer patients’ information needs by 
outlining their desired types of cancer health information and the information sources used. This 
section examines patients’ met and unmet information needs and overall satisfaction with health 
information.   
Accessibility to credible, accurate, and authoritative information is imperative for all 
patients, including those with rare diseases and cancers, so that they can make informed 
decisions about their health. The information that patients find often impacts health care 
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decisions (Tozzi et al., 2013). Rutten’s et al. (2005) review of the literature regarding cancer 
patients’ information needs found that cancer information provision resulted in many benefits.  
These benefits included: an increased patient participation in decision making; increased 
treatment satisfaction; increased coping ability (Spring, 2014); reduced anxiety; and better 
communication with family. 
 Moreover, meeting information needs is important, as unmet needs are associated with 
negative health-related quality of life (Miyashita, Ohno, Kataoka, Tokunaga, Masuda, & Shien, 
2015); high levels of anxiety and depression (Halkett et al., 2012); negative illness perceptions; 
and higher negative impact of cancer (Husson Mols, Oranje, Haak, & Nieuwlaat, 2014). General 
cancer patients report information needs impact their lives.  Likewise, patients with rare diseases 
in a study by Huyard (2009) found their informational needs so important that they reported that 
it was the physician’s moral obligation to provide them with authoritative, credible information.  
Rare disease patients in the study reported their overall health care experience would be 
improved if health care providers not only provided an adequate diagnosis, but also provided 
adequate information to the patient about the condition.   
 Meeting cancer patients’ information needs is important; unfortunately, cancer patients 
often report that their needs were not adequately met (Rutten, Squiers & Hesse, 2006).  In a 
study by O’Connor, Coates and O’Neill (2010, p. 275) of 40 patients with rectal cancer, patients 
reported having high levels of information needs; however, they reported that their needs were 
largely not met.   Patients in the study reported receiving inadequate information about testing 
and “long-term physical, psychological and social sequelae of the disease.” Likewise, Halkett’s 
et al. (2012) study of breast cancer patients receiving radiotherapy found that many of the 
women’s specific information needs regarding treatment effects were unmet or only partially 
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met. Husson et al. (2014) found that nearly half of thyroid cancer survivors responded that they 
were, “not at all,” or “little satisfied” with the amount of information they received about thyroid 
cancer, and in particular were less satisfied with information they received about long-term 
effects, recurrence, aftercare, and current information about the disease. 
 Like patients diagnosed with cancer, patients with rare diseases, including rare cancers, 
often do not have their information needs met and are dissatisfied with the information they have 
received.  Many patients with rare diseases report finding it difficult to obtain information about 
their rare conditions (Armstrong, Rochnia, Harries, Bundock, & Yorke, 2012; Budych, Helms, & 
Schultz, 2012; Feinberg et al., 2013; Huyard, 2009; Lim, Downs, Li, Bao, & Leonard, 2012; 
Mooney, Poland, Spalding, Scott, & Watts, 2013). 
  For example, Huyard (2009) conducted semi-structured interviews of 29 patients and 15 
parents of patients diagnosed with rare diseases. The study found that patients with rare diseases 
expect not only to be well treated as patients, but to be listened to, taken seriously, and supported 
and informed according to need (Huyard, 2009). Patients who reported being dissatisfied with 
the diagnosis experience with their physician reported, among other reasons, “inadequate 
provision of information about the disease (Anderson, Elliott, & Zurynski, 2013, p. 4).”  
 In a rare cancer blog entry, Jan Geissler, Director of the European Cancer Patient 
Coalition states, “I believe that empowerment of patients is a pre-requisite for health, and access 
to high quality health information is fundamental to achieve this.  [Patients] regard access to 
information as a fundamental right, as long as it meets stringent quality principles.  Patients, 
especially those with a rare disease, are particularly isolated and vulnerable without effective 
access to information” (Geissler, 2010). 
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As shown above in examining information satisfaction and met and unmet needs of 
cancer patients and patients with rare diseases, meeting patients’ information needs is important 
as unmet needs and low satisfaction with health information can be associated with many 
negative factors, including reduced satisfaction with care, trust in physician, and health-related 
quality of life (Husson Mols, & Van de Poll-Franse, 2011).  These three factors are important in 
the overall health of cancer patients, as described below. 
 Patient satisfaction. Varying definitions of “patient satisfaction” exist due to the 
difficulty of defining the term “satisfaction” (Williams, Weinman & Dale, 1998).   Bredart, 
Bottomley, Blazeby, Conroy, & Coens, (2005, p. 2121) define patient satisfaction as, “the extent 
to which an individual’s health care experiences match his or her expectations.” Kamo, 
Dandapain, Miksad, Houlihan, & Kaplan, (2010) expand this definition to encompass health care 
experiences increasing the possibility of the patient receiving favorable health outcomes. In 
general, patient satisfaction is used for measuring the quality of health care received by patients 
(Prakash, 2010).   
  The literature shows that patient satisfaction is important because it is related to patients’ 
following of physician recommendations, cancer treatment adherence, and health status 
improvement (Bleich, Ozaltin, & Murray, 2009; Bredart et al., 2005).  Bleich et al. (2009) found 
that in addition to patient satisfaction being related to increased treatment adherence, patients 
who are satisfied with their healthcare experience are generally more compliant and cooperative.  
Gupta (2012, p. 766) states, “…there has been a recent rise in awareness that patients’ 
satisfaction with the quality of the services they receive at a healthcare institution can affect their 
treatment outcome.”  Results of Gupta’s (2012) study of patients diagnosed with pancreatic 
cancer showed that patient satisfaction was an independent predictor of survival.   
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 Patient trust in physician. While trust is important in any relationship, it is a particularly 
integral and important part of the patient-physician relationship (Anderson & Dedrick, 1990; 
Hillen, de Haes Hanneke, & Smets, 2011; Kaiser, Rauscher Jacobs, Strensk, Ferrans, & 
Warnecke, 2011; Pearson & Raeke, 2000).  There are varying definitions of the concept of trust 
in a physician.  Trust can be defined as the patient’s set of beliefs about how their physician will 
perform in a certain way (Pearson & Raeke, 2000).  Trust may also be defined more affectively 
using the patient’s “reassuring feelings” or “feelings of confidence” in the physician as a basis of 
trust (Pearson & Raeke, 2000).  Definitions also encompass qualities which patients expect their 
physician to possess and can include: competence, compassion, maintenance of privacy and 
confidentiality, reliability, dependability, and good communication skills (Pearson & Raeke, 
2000).  A study by Hillen et al. (2011) found that other components of physician trust among 
patients were perceived technical competence, honesty, and patient-centered behavior. 
It is important for patients to have trust in their physicians.  Pearson and Raeke (2000, p. 
512) state, “Theoretically, patient trust should serve to reinforce the functioning of the clinical 
relationship as a health partnership, thereby increasing the probability of patient satisfaction, 
treatment adherence and improved health status, while decreasing the likelihood of leaving the 
physician’s practice or withdrawing from a health plan.”  The literature shows that increased 
patient trust leads to greater treatment adherence (Pearson & Raeke, 2000; Kaiser et al., 2011; 
Hillen et al., 2011); patient satisfaction (Pearson & Raeke, 2000; Kaiser et al., 2011; Hillen et al., 
2011); facilitated communication; medical decision making; and decreased patient fear (Hillen et 
al., 2011).  In a study of patients with cancer, Hinnen, Pool, Holwersa, Sprangers, and 
Sanderman, (2014) found that low levels of trust in physician were associated with increased 
emotional distress and increased physical limitations.  Kaiser et al. (2011) found that a trusting 
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relationship with a regular provider facilitates trusting relationships with other health care 
providers on the care team.  
 Health-related quality of life. Health-related quality of life (HRQL) is the subjective 
perception of the patient’s overall wellbeing, encompassing emotional and physical health and its 
impact on the patient’s life (European Organization for Research and Treatment of Cancer, 
2014).  Traditionally, the outcomes of focus were on the narrow measures of mortality and 
morbidity (Centers for Disease Control and Prevention, 2011).  Now, measures are expanded to 
include outcomes of HRQL in addition to morbidity and mortality. This reflects that more people 
are living longer with chronic illnesses, including cancers that may have limited treatments but 
not a cure (Institute of Health Economics 2008). Thus, with patients living longer with illnesses, 
it is essential that their physical, mental, and social lives are also improved. 
 Measuring HRQL is important because it assesses the positive and negative impacts of 
chronic disease and treatment on patients’ overall wellbeing.  Additionally, HRQL measures 
assess the current health status of the patient.  This is vital due to the wide variability of patients’ 
HRQL even if they have the same disease and are undergoing similar treatment (Institute of 
Health Economics, 2008).   
 HRQL is now considered critical to patient care and researchers are beginning to explore 
the relationship between HRQL and patients’ overall survival (Lemonnier, Lewis, Ahmad, & 
Sullivan, 2014).   In a study of non-small cell lung cancer patients, Efficace, Bottomley, Smith, 
Lianes, and Legrand (2006) found that self-reported HRQL provides independent prognostic 
information for survival.  There was an increase in deaths for those who self-reported worse 
HRQL (Efficace et al., 2006). 
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 Since we know that information access and satisfaction of informational needs contribute 
to patients’ well-being, or can positively or adversely affect patients, we must begin to provide 
more/credible information for patients with rare cancers.  The following section provides the 
conceptual framework used for this study that shows health information needs, sources, and 
information satisfaction in the context of health-related quality of life.  
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Theoretical Framework   
 This research study draws upon Johnson’s Comprehensive Model of Cancer Information 
Seeking (CMIS) to conceptualize information needs and information seeking behavior of 
patients with rare cancers.  First, an explanation of the CMIS will be presented, followed by the 
conceptual model that was used in this study. 
 Johnson’s comprehensive model of information seeking. The CMIS posits that 
antecedents motivate patients to seek information and information carrier factors lead to 
information seeking actions.  The CMIS model is shown in Figure 1 below and a brief overview 
of the model’s constructs will follow. 
Figure 1.  Johnson’s Comprehensive Model of Cancer Information Seeking 
 
(Johnson, 1997) 
Antecedents: The antecedents of CMIS are factors that motive a person to seek 
information and are comprised of the concepts of demographics, experience, salience and beliefs. 
Demographic Factors: Research has shown that consumers’ usage of sources of health 
related information varies by demographic factors (Johnson, 1997).  For example, information 
searching behavior and information needs vary by age.  Rutten (2006) examined informational 
needs of cancer patients who actively seek cancer information by socio-demographic status using 
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2003 HINTS survey data and found that younger aged cancer patients were more likely to seek 
health information than those aged sixty-five or older.  Additionally, information seeking varies 
by gender. Females are more likely than males to search for cancer information (Rutten, 2005, 
2006).  Another example of demographic differences is educational level. Those with a college 
degree or reporting “some college” are also more likely to seek out cancer health related 
information than those who did not report any college experience (Rutten, 2006).  Race/ethnicity 
also varies between those patients who search for cancer-related information online and those 
who do not (Castleton, 2011, Rutten, 2006).    
Experience: The second antecedent in the CMIS model is experience.  Direct experience 
predicts health information seeking.  A person’s own symptoms or experience with cancer may 
prompt him or her to seek health information.  Examples include personally being screened or 
treated for cancer and having a friend or family member who is screened for cancer (Johnson, 
1997). 
Salience and beliefs: Salience and beliefs are motivational factors for seeking health 
information to fill a knowledge gap.  Salience is the belief that health information will actually 
fill a knowledge gap.  Beliefs encompass a person’s belief that there is something that can be 
done to improve his or her medical condition.  If a person believes that there is a medical therapy 
available that can improve his or her medical condition or that there is a test that can detect 
cancer, the person will seek health information (Johnson & Meischke, 1993). 
Information Carrier Factors:  First, the term “carrier” in the CMIS model is used to 
describe any informational source or information channel (i.e. print, video, physician).  
Information carrier factors are the second column of the CMIS model and are comprised of two 
concepts: characteristics and utilities.    
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Characteristics:  This concept describes characteristics that health information seekers 
desire in the information sources they are using.  For example, characteristics may include source 
credibility, editorial tone, or reading level of the information (Johnson, 1997) 
Utilities: The second concept of information carrier factors is utility.  Utility is related to 
the user’s perceived usefulness of the information carrier. Characteristics, described above, make 
the information carrier useful.  Describing utility, Johnson and Meischke, (1993, p. 349) ask, “… 
is the information contained in the medium important for the individual’s purposes, relevant, and 
topical?”  Utility of the information in CMIS leads to the concept of information seeking actions.  
Information Seeking Actions: Antecedents and carrier factors predict information 
seeking actions.  While the CMIS provides a framework for predicting information actions, it 
lacks a final outcome of patient health behavior.  Anker, Reinhart and Feeley, (2011) expand the 
CMIS model by placing it in the context of health behaviors (see figure 2).  This modification of 
the CMIS, integrating health behavior, is the basis for the conceptual model for this study (see 
figure 3) outlined in detail below.   
Figure 2. Information Seeking in the Context of Health Behavior Outcomes 
 
   
(Anker et al., 2011) 
 Conceptual model describing rare cancer patients’ information seeking. Owing to a 
lack of theoretical models explaining information seeking in context of health, the conceptual 
model used for this study integrates Anker’s et al. (2011) model into the CMIS to provide a 
conceptual framework that incorporates associated health behavior outcomes in addition to 
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health information seeking. Figure 3 below demonstrates the model and a more detailed 
explanation of the model follows.  
Figure 3. Conceptual Framework 
 
 
 
  
 
 
 
 
 
 
 
 
 In the conceptual framework used to guide this study, “predisposing characteristics” 
(called antecedents in the CMIS) are those characteristics that lead or motivate patients with rare 
cancers to seek information.  These characteristics include demographics and direct experience.  
Information seeking varies by gender, age, and race.  Direct experience can be defined as a 
patient’s experience with rare cancers.  Being screened, diagnosed, or treated for a rare cancer 
are all considered predictors to seeking information about rare cancers. 
 The motivational factors of the predisposing characteristics are salience and beliefs. 
Salience and beliefs provide the motivators to the background factors to actually engage in 
information seeking.  If patients with rare cancers believe that there is information about their 
rare cancers (salience) and believe something can be done to improve their health, they will 
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engage in information seeking.  For example, if patients believe there is a treatment available for 
their rare cancers, they will seek out information about treatment.   
These predisposing characteristics motivate or predict actual engagement in health 
information seeking (information carrier factors in CMIS).  Health information seeking is 
defined as, “the purposive acquisition of information from selected information carriers (Johnson 
& Meischke, 1993, p.350).”  Engagement in health information seeking is comprised of 
characteristics and utilities.  Characteristics include information needs (types of information 
sought) and sources used.  
The second concept of engagement in information health seeking is utilities.  Utilities 
pertain to the usefulness of the information and answer the questions, “Was the patient satisfied 
with the information and did the patient receive information from his/her preferred information 
source?”  Utilities, measured as satisfaction with information, leads to associated health behavior 
factors.  In this study the associated health behavior factor being studied is health-related quality 
of life.  For example, patients with information needs that are not met (unsatisfied information 
needs) may report a decreased health related quality of life as compared to patients whose 
information needs were satisfied.   
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Chapter III. Specific Aims and Research Questions 
This research study examines the unique health information needs and sources of 
information of patients who have been diagnosed with rare cancers.  Due to the lack of 
information on rare cancers for patients, this study also examines the relationship between rare 
cancer patients’ satisfaction with health information, and their health-related quality of life. 
The three specific aims of this study and their associated research questions are: 
Specific Aim 1:  Examine the information needs of patients who are diagnosed with a rare 
cancer. 
RQ1: What types of cancer-related health information are desired by patients diagnosed 
with rare cancers? 
RQ2: Do information needs vary by demographics: gender, age, and race?  
Specific Aim 2:  Examine the information sources used and preferred by patients with rare 
cancers. 
RQ3: What sources do patients use to find information about their rare cancers? 
RQ4: What sources do patients prefer when seeking information about their rare cancers? 
Specific Aim 3:  Examine patients with rare cancers’ satisfaction with information and its 
association with health-related quality of life  
RQ5: Are patients with rare cancers satisfied with the information they receive? 
RQ6: Is information satisfaction related to health-related quality of life? 
 Based upon the literature review detailed above, it is hypothesized that rare cancer 
patients’ unsatisfied information needs will have a negative association compared to rare cancer 
patients who report having a higher level of information satisfaction.  For example, patients who 
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report having unsatisfied information needs will report a lower perceived health-related quality 
of life as compared to patients who report a higher level of satisfied information needs.   
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Chapter IV. Research Design and Methods 
 
Study Overview 
 This cross-sectional design study used mail surveys to assess the cancer information 
needs, information sources, and the relationship of health related quality of life to information 
satisfaction of patients diagnosed with rare cancers. Validated measures were used to collect data 
on cancer information needs, information sources, and source preferences. Additionally, 
validated measures were used to collect data on participants’ satisfaction with information, as 
well as patient health-related quality of life. The overall purpose of this study is to describe rare 
cancer patients’ information needs, information sources and source preferences, and to determine 
whether information satisfaction is associated with health-related quality of life.  
Study Site  
 The study was conducted at the Virginia Commonwealth University Massey Cancer 
Center (MCC).  The MCC is a National Cancer Institute (NCI) designated cancer center. In 
2014, a total of 15,087 patients visited the MCC for consultations and treatments including 
chemotherapy, bone marrow transplantation, surgical procedures, and radiation therapy.  In 
2014, 5,814 new patients were seen comprising a patient population of 57% Caucasian, 38% 
African-American, and 5% other races.   
List of Rare Cancers 
 The list of rare cancers used to identify eligible patients is derived from rare cancers 
included in the Textbook of Uncommon Cancers (2012) edited by Derek Raghavan MD, Medical 
Oncologist and President of the Levine Cancer Institute at Carolinas Health Care System.  The 
textbook editorial board is comprised of six other oncology specialists, in addition to Dr. 
 43 
 
Raghavan.  The cancers included in the text were selected by oncologists in each cancer specialty 
area, with 198 cancer specialists contributing information.  Each oncologist was responsible for 
identifying rare cancers in his/her area of specialty.  All cancers, other than cancers identified in 
the pediatric cancer sections of this book were included in the rare cancer list used in this study.   
 Additionally, the compiled cancer list used for this study includes cancers from the Office 
of Rare Disease Research (ORDR) rare cancer list that were not included in the Textbook of 
Uncommon Cancer. Diseases on the ORDR list were included if they were an unusual cancer 
cell type. The following disease types on the ORDR list were excluded: those that are not 
specific cancer types; hereditary syndromes; syndromes that are not cancers but increase cancer 
risk; and precancerous conditions. Cancers were also excluded if they were exclusively pediatric 
cancers.  Laurie Lyckholm, MD, Professor, Department of Hematology/Oncology, Holden 
Comprehensive Cancer Center, University of Iowa, assisted with the development of the rare 
cancer list that is included in this study and the inclusion/exclusion criteria for selecting cancers 
from the ORDR list. The list was comprised of approximately 500 different types of cancers that 
are considered rare.   
 This study was approved by the Virginia Commonwealth University (VCU) Institutional 
Review Board.  
Study Sample 
 Inclusion criteria. Eligible participants (N = 113) were patients diagnosed with rare 
cancers of any type or stage being treated by a medical oncologist, radiation oncologist, or 
surgical oncologist at the MCC.  Eligible patients must have been diagnosed within twelve 
months prior to being contacted for participation, aged 18 years or older, and fluent in the 
English language.  
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 Exclusion criteria. Patients who did not have a diagnosis of a rare cancer were excluded 
due to this study specifically examining the information needs and information sources of those 
patients who have rare cancers.  Patients who were diagnosed more than twelve months 
previously were not eligible because they may have satisfied a greater number of information 
needs given the length of time since diagnosis or may have forgotten their information needs, 
resulting in response bias. Patients younger than 18 years of age were also excluded from this 
study as this study seeks to examine the information needs and sources of adult patients, not that 
of children or the parents of children with cancer.  Those who were not fluent in the English 
language were excluded since all measures used are written exclusively in the English language.  
Those patients known to be incarcerated currently or incarcerated at the time of diagnosis were 
also excluded from the study. Finally, patients were also excluded if they were deemed not 
appropriate for contact or participation by his/her oncologist. 
 Recruitment. A HIPAA partial waiver of authorization to use protected health 
information (PHI) was approved by the VCU IRB for purposes of identifying patients eligible to 
participate in the study. 
 To identify eligible participants, the researcher collaborated with Massey Data Analytics. 
The rare cancer list was used to match patients listed in the Massey Cancer Center cancer patient 
registry which is provided by the Massey Cancer Center Cancer Informatics Core and is updated 
on a six-month time delay from the patient’s date of diagnosis.  Each month, Massey Data 
Analytics emailed the researcher a password protected Excel spreadsheet containing a list of 
patients who were diagnosed with a rare cancer included in the rare cancer list and who met all 
eligibility requirements. Patients who were known to be deceased were excluded. Patients were 
determined to be deceased based upon VCUH hospital billing data, the Social Security Death 
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Index Data, and the cancer registry data vital status. Prisoners at the time of diagnosis and those 
currently incarcerated were also excluded. Prisoner status was determined by payer status listed 
as, “corrections,” and the latest available address in the billing data or registry data.  The list of 
patients meeting eligibility criteria was also matched against prior lists sent to the researcher to 
exclude patients previously included in the rare cancer patient list. The MCC data analytics’ 
spreadsheet contained the following information: medical record number, patient name, 
diagnosis date, primary cancer site description, histology description, grouped histology 
description, behavior code (malignant), cancer stage, treatment status, and patient address.  
 In advance of mailing survey letters, the researcher contacted Massey Cancer Center 
oncologists and nurse practitioners via email and provided them details of the study. The 
oncologists and nurse practitioners were asked to contact the researcher if they had questions 
about the study, did not wish survey letters to be mailed to specific patients, or if they did not 
wish us to contact any of their patients with rare cancers.   
This study used mail surveys to assess the information needs and information sources 
used by patients who have been diagnosed with rare cancers. The process for implementing the 
mail surveys followed the Tailored Design Method (Dillman, 2014) formerly known as the Total 
Design Method (Dillman, 1978).  The Tailored Design Method uses concepts from social 
exchange theories and tailored design to motivate people to respond to written surveys.  The 
Tailored Design Method promises a high response rate of at least 80% when following the 
specific detailed steps for conducting mail surveys (Dillman, 1978, Hoddinott S, Bass, 1986).  
By following this method, Hoddinott & Bass (1986) achieved a mailed survey return rate of 
92.8%. The Tailored Design Method steps employed in this study are described below.  
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A timeline of mailings is found in Table 1 below. A preliminary introductory letter 
(Letter 1) was sent to all eligible patients introducing them to the study and providing a brief 
overview and contact information (phone number and email address) for them to opt out of 
participating in the study or to ask questions.  Patients opting out were not sent any further letters 
regarding the study. Letter 1 also informed patients that they would be receiving a survey in the 
mail along with a written letter of request for participation in approximately one week.  All 
patient and return addresses for the envelopes were hand-written and all letters and envelopes 
used VCU School of Medicine letterhead. 
 One week after mailing the introductory letter, an initial invitation letter/packet (Letter 2) 
was mailed to the patient.  This contained a cover letter providing more details about the study, 
the survey booklet, a self-addressed stamped return envelope, and $2.00.  The cover letter stated 
that by completing and returning the questionnaire, the patient was consenting to participate in 
the research study. The letter provided contact information, both telephone and email for the 
patient to ask additional questions about the study or to opt out of the study.   The survey booklet 
contained all of the survey questions which were logically arranged in an easily understandable 
style (see appendix A).  The survey booklet cover was tailored to the audience of patients 
diagnosed with rare cancers by using images to which they can relate. The survey was designed 
to be inviting to the patient, as well as easy to complete.  The survey booklet contained a unique 
individual identification number at the bottom of each page linking to each patient.  This 
identification number was used to avoid sending mailings after the thank you/reminder letter 
(letter 3) to those who had completed and returned the survey.  A self-addressed stamped return 
envelope was included to lessen the burden on patients in returning the survey booklet.  The 
return address was written on the final page of the survey booklet in case the participant lost the 
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return envelope.  The last item included in the packet was a token $2.00 as a “pre-thank you” 
incentive for completing and returning the survey that patients could keep regardless of whether 
or not they actually completed and returned the survey. 
 A week after mailing the initial invitation packet, a thank you/reminder letter (Letter 3) 
was mailed to everyone regardless of whether or not the patient had returned the survey unless 
they had opted out of participating in the study.  This letter served to thank those who had 
responded and also reminded those who had not yet completed and returned the survey to do so. 
 Fourteen days following the thank you/reminder letter, a follow-up reminder packet 
(Letter 4) was sent to the patient if he/she had not responded by that time.  This packet included a 
brief overview letter, an identical copy of the survey booklet with the patient’s unique 
identification number at the bottom of each page, and another self-addressed, stamped return 
envelope.  This letter served as a reminder and also included another survey and return envelope 
in case the original survey had been lost or discarded.  
 A final reminder (Letter 5) was mailed four weeks after the follow-up reminder packet 
was sent to patients who had not yet returned their surveys.  This letter served as a reminder to 
complete and return the survey and to let the patient know that we would not be contacting 
him/her further regarding the study.  Applying the Tailored Design Method process, this letter 
was sent using priority mail.  The purpose of a different mail delivery format is to pique the 
attention and interest of the recipient, emphasize the importance of the letter, and increase the 
likelihood that the survey would be completed and returned.  
 All patients deemed eligible to participate were sent letters 1-3 unless they had contacted 
us following Letter 1 requesting to opt out of further participation.  Those not responding 
following Letter 3 were sent follow–up letters (Letters 4 and 5).  Letters 1-3 also followed the 
 48 
 
timeline suggested by the Tailored Design Method. Due to a back-up in receiving mail at the 
university, completed surveys were delivered in large batches of ten or twenty, rather than 
individually as they arrived at the post office.  These mail batches arrived in infrequent intervals, 
approximately every six to eight weeks.  Due to this mail delivery constraint, and by strictly 
following the Tailored Design Method suggested time frame, some patients were sent Letter 4 
(which contained an identical survey) when they had already completed and returned the first 
survey sent with Letter 2.  This led to confusion and three patients returned both the first survey 
sent to them and the reminder survey.  As a result, we adjusted the time frame for mailing Letters 
4 and 5 based upon the return rates of surveys.  Letter 4, which included the reminder survey, 
was not sent until after approximately 50% of the surveys sent following Letter 3 were received.  
The final letter, Letter 5 was sent approximately eight weeks following Letter 4 to allow time to 
receive surveys in the mail. This was intended to reduce participant confusion and ensure we no 
longer received duplicate surveys.  
Table 1: Timeline of mailings following the tailored design method 
Letter Description Mailing 
Timing 
(weeks)  
Letter 1 Introductory Letter 1 
 
Letter 2 
 
 
Recruitment Letter and 
Survey 
2 
Letter 3 
 
Thank You/Reminder Letter 3 
Letter 4 
 
Reminder Letter and Survey 5 
Letter 5 Final Reminder Letter 
Priority Mail 
9 
 
 Data received from the returned surveys were entered via key punch method into an 
Excel spreadsheet. Because three surveys were duplicates that arrived in batches (without a date 
postmark on the envelopes) it was difficult to determine which was the first survey the 
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participant completed, so the researcher randomly selected one from each set of duplicates and 
entered the data received from the randomly selected surveys into the spreadsheet.  The duplicate 
survey was stapled to the back of the survey used for data entry and was marked, “duplicate.” 
Upon completion of data collection and data entry, data were then imported into JMP (Version 
12.0) statistical software for analysis. 
 Meeting recruitment goals. A plan was made for meeting recruitment goals. According 
to the MCC patient census records, a conservative estimate of 1030 patients (13.83%) were 
diagnosed with rare cancers listed on the Office of Rare Disease Research cancer list over a 
three-year time period, corresponding to an average of approximately 343 rare cancer patients 
annually eligible to participate in the study.  Assuming a conservative estimate of a 50% 
participation rate, 172 patients annually were likely to participate in this study.  This means that 
the needed sample size (N=100) for this study would easily be met.  Attrition was not a 
consideration because the subjects were only surveyed at one-time point.   
Sample Size and Power Analysis 
 Based upon the power analysis, a final sample size of 100 was used for this study.  The 
power analysis calculations were based on research question number two, “Do information needs 
vary by demographics (gender, age, and race)?” since this research question requires the largest 
sample size to detect a significant effect.  The sample size of 100 provides 97% or higher power 
to detect medium or moderate (range: .23 - .38) effect sizes.  The power analysis type 1 error rate 
was .05. 
Data Collection Procedures and Measurement 
 The mail survey session was anticipated to take approximately ten to fifteen minutes to 
complete.  By completing and returning the survey, patients were informed they were consenting 
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to participate in the study. Data were collected on: 1) socio-demographics; 2) cancer information 
needs; 3) patients’ received information and information satisfaction; 4) information sources 
used and preferred; and 5) health-related quality of life.  
Variables and Measures 
The following socio-demographic data were collected from the patient via survey: 
gender, age, race, type of medical insurance coverage, employment status, and income.  
Description of Measures and Scoring (See appendix A for the survey containing measures and 
questions used in this study) 
The European Organization for Research and Treatment of Cancer (EORTC) Quality of 
Life Questionnaire-Information scale (EORTC QLQ- (Information) INFO25). 
Cancer Information Received, Information Needs, and Information Satisfaction were assessed 
using standardized and modified questions from the European Organization for Research and 
Treatment of Cancer (EORTC) Quality of Life Questionnaire-Information scale (EORTC QLQ-
INFO25).  The EORTC QLQ-INFO25 measure is valid and reliable. The instrument correlated 
with the EORTC Cancer Inpatient Satisfaction questionnaire (IN-PATSAT32) (r>.40), showing 
convergent validity and had a low correlation with the EORTC general cancer scale (EORTC 
QLQ-C30) showing divergent validity.  Internal consistency (Cronbach’s alpha>0.90) of all 
items combined proved reliability of the measure (Arraras, Greimel, Sezer, Chie, & Bergenmar, 
2010).  The measure has been used in studies of patients with various types of cancers and in 
culturally diverse populations (Arraras et al., 2010; Husson et al., 2014). 
Cancer Information Received: This 25 question instrument asks the stem question, “During your 
current disease or treatment, how much information have you received on…” followed by health 
information types such as “diagnosis,” “treatment,” and “procedures.” Question responses are 
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measured on a four point Likert-type scale anchored by 1 (not at all) on one end and 4 (Very 
much) on the other.  
In order to assess additional information received, four stem questions were added to this 
measure: 1.) The effects of treatment on fertility (the ability to have a baby); 2.) Other treatment 
options; 3.) Financial, insurance, and work-related resources; and 4.) Whether family members 
are at risk for cancer. 
Cancer Information Needs: In addition to the above questions that assess information 
provision, the EORTC QLQ-INFO25 questions were modified to assess information needs. The 
questions in this instrument were modified to ask, “During your current disease or treatment did 
you/do you need information on…” Responses for these questions are on a four point Likert-type 
scale anchored by 1 (not at all) on one end and 4 (Very much) on the other. 
Information Satisfaction: Information satisfaction was also assessed using the EORTC 
information received question, “Were you satisfied with the amount of information you 
received?” This question was modified to “Overall were you satisfied with the information you 
received?” to assess general information satisfaction. The original EORTC information 
satisfaction question was on a four-point Likert-scale ranging from “not at all” to “very much.” 
The response options for this survey were dichotomized to a “Yes” or “No” response for ease of 
response for participants and to facilitate analysis. 
EORTC QLQ- INFO-25 Scoring:   
Scoring EORTC QLQ-INFO25. Following directions from the manual, scores for both 
information needs and information received were linearly transformed into a 0-100 scale.  First, a 
raw score, which is the mean of the component items was calculated for each scale: information 
about disease, information about medical tests, treatment, other services, different places of care, 
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and things you can do to help yourself.   The raw scores were then linearly transformed into a 0-
100 scale. Higher scores indicate a higher information need and higher information received. 
 Raw Score (RS)=(I1+I2…In)/n   
Where I=component item (Likert-score) and n=the number of questions included 
in the scale 
 Linear Transformed Score (S)={RS-1}/range}*100  
 The range equals the maximum possible response value minus the minimum possible response 
value. Therefore, a 1-4 response scale’s range is equal to 3 and the range for any yes/no (binary) 
response items is 1. 
Following the EORTC QLQ-INFO25 manual, missing data were set to missing if more 
than half the data were missing from a particular participant for the particular scale being scored.  
Also, any single item was set to missing if not answered. If less than half the data for the scale 
were missing, then the missing data were imputed by simply ignoring the missing data and 
calculating the raw score by dividing by the number of questions in the scale that have a 
response.  For example, if item 3 is missing then, RS=(I1+I2+I4)/3. 
Each individual information item was also transformed into a 100-point score. For each 
information item (individual questions), raw scores, (since they only consisted of one item) when 
converted using the formula above were essentially the Likert response score.  The raw score 
was linearly transformed into a 100-point score using the same formula as above.  Due to these 
being single questions only, data were unable to be imputed, so any missing items were set to 
missing in the database. 
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The Health Information National Trends Survey (HINTS). Information Sources and Source 
Preferences were ascertained using modified questions from the Health Information National 
Trends Survey (HINTS) developed by the United States National Cancer Institute.  HINTS is a 
national survey that collects data regarding the use of cancer-related information in the United 
States.  The HINTS survey has been administered in 2003, 2005, 2007, 2011 2012, and 2013.  
HINTS survey questions are derived from pre-existing national surveys and created by the 
HINTS program in 2001 (Nelson, 2004).  Psychometric properties of the questions used in the 
HINTS survey are ensured through careful testing of each item (Health Information National 
Trends Survey [HINTS], 2014; http://hints.cancer.gov/faq.aspx). It is a standardized and 
accepted measure (Nelson, 2004). HINTS 2003 and 2005 were administered solely via telephone 
with questions being read to respondents and in 2007 HINTS was administered in two modes: 
via telephone and mail (Health Information National Trends Survey, 2014).  The questions used 
in this study were taken from the HINTS “Cancer Communication” section and focus on cancer 
information sources.  
One HINTS question included in the survey provides a list of sources and asks the 
participant to respond by indicating all the sources from which they sought information the first 
time they looked for information.  This question was included in this study’s survey followed by 
two added questions (that are not in the HINTS survey) using the same sources listed in the 
HINTS question. These two modified questions ask what sources the patient has used to seek 
information; and the second modified question asks where the patient prefers to receive 
information. The following list of sources from the HINTS survey was included for patients to 
select: books; brochures and pamphlets; cancer organization; family; friend/co-worker; doctor or 
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health care provider; Internet; library; magazines; newspapers; telephone information number; 
complementary, alternative, or unconventional practitioner; and other (specified).    
HINTS scoring: Responses for this measure were reported as frequencies and percentages. 
Health-related quality of Life 
The Short-Form Health Survey (SF-12 v.1). Health-Related Quality of Life was assessed using 
the Short-Form Health Survey (SF-12 v.1) (License # QN035780) (Ware et al., 1996), a reduced 
instrument of the longer 36-item Short-Form Survey (SF-36) from the Medical Outcomes Study.  
The SF-12 measures two domains of quality of life: mental health and physical health. It 
correlates well with both the SF-36 physical component (R2 =0.911) and the mental component 
(R2=0.918). The 12-item measure is both valid and reliable (Cronbach’s alpha>.80).  The item 
response options are on a five-point Likert-scale ranging from 1 (excellent) to 5 (poor).  The SF-
12 has been used in multiple studies to assess health-related quality of life in cancer patients 
(Hamoen, De Rooij, Witjes, Barentsa, & Rovers, 2014; Neuner, Zokoe, McGinley, Pezzin, & 
Yen, 2014).  
SF-12 v.1 Scoring: 
Scoring for the SF-12v.1 was conducted using the client version 5.0 desktop scoring software 
provided by Optum (https://campaign.optum.com/optum-outcomes/what-we-do/health-
surveys/sf-12v2-health-survey.html).  The scoring software allows for missing score estimation 
and calculates both the physical component and mental health component scores of the SF-12 
Health Survey.  The software uses norm-based scoring, with the norm equaling 50.  Higher 
scores indicate better health for both the physical health component and the mental health 
component, where lower scores indicate worse health for both physical and mental components. 
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Analysis Plan 
 Surveys and letters mailed and received are reported. The date mailed for each group of 
surveys sent is reported along with the number of letters sent for each mailing (letters 1-5).  The 
number of surveys returned for each group is reported with frequencies and percentages.  The 
number of patients reported by a family member as having died is reported for each group with 
percentages. Finally, the frequency and percentage of patients who requested to opt out of 
participating in the survey for each mailing group is reported. The participation rate is reported 
as frequency and percentage. 
Descriptive analyses were used to characterize participant demographics: gender, age, 
race, employment status, insurance coverage status, and household income. Categorical variables 
(e.g., race, gender, employment status, insurance coverage and household income) are reported 
with frequency and percentages.  Continuous variables: age, information needs scaled scores, 
information received scaled scores and health-related quality of life scores are reported with 
means and standard deviations.  
 JMP (Version 12.0) was used for all analyses.  The significance level for all analyses is 
α=.05. Below are the research questions along with the statistical analyses that were used for 
each. 
RQ1: What cancer-related health information is sought by patients diagnosed with rare 
cancers? Descriptive statistics were used to summarize the data regarding the health information 
that was reported needed and received by participants. Each cancer-related information type was 
listed with the corresponding percentages of information types reported that were needed by 
participants and the same was done for information reported received.  The data are listed in two 
frequency distribution tables (one for information needs and another for information received) 
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that included the type of information; number of respondents reporting each type; and percentage 
of respondents reporting each type of information for each response: “not at all, “a little,” “quite 
a bit,” and “very much.”  The mean scaled scores for each subscale and item are also reported 
with standard deviations.  
Unmet needs. The difference in information needs and information received (unmet 
needs) was scored by calculating scale scores for information needs and information received for 
each subscale: disease subscale, medical tests subscale, treatment subscale, other services 
subscale, and the individual items: different places of care, and things you can do to help 
yourself get well.  The same was done for each of the individual information need and 
information received items. For each subscale and individual item, the average raw score and 
scaled score are reported. Additionally, each information need items and each information 
received items were linearly converted.   
As previously described, larger mean scores indicate greater information needs or greater 
information received.  To calculate unmet needs, the scaled score means of information received 
was subtracted from information needs scaled score means.  A positive value indicates that 
information needs were greater than information received.  A negative value indicates higher 
amount of information received than needed. 
Information needs and received scales’ means were compared.  A two-sample T-test was 
used to test the null hypothesis that the information needs and information received scales’ 
means are equal against a two-sided alternative hypothesis that the means are not equal.  Data 
were assumed normal based on the Central Limit Theorem given that n>30.  A Brown-Forsythe 
test was conducted to check for equal variances.  If variances were not equal a Welch’s test was 
used. Information needs and received means for each scale are reported with the standard 
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deviation.  Differences between the means are reported with standard error, 95% confidence 
intervals, and p-value.  In addition to comparing the means of the information needs and 
information received scales, means were also compared at the individual item level for all 23 
information need items and information received items using the same analyses as outlined 
above for the information subscales. 
RQ2:  Do information needs vary by demographics: gender, age, and race (Whites and non-
Whites). 
Information needs. Information need levels were dichotomized into low needs and high needs. 
“Not at all” and “A little” were scored as 1 (low needs) where “Quite a bit” and “Very much” 
were scored as 2 (high needs).  For the binary variables of gender (male and female) and race 
(White/non-White), a two sample Pearson chi-square test was used to compare the difference in 
the two groups’ proportions of information needs.  The null hypothesis that the proportion of no 
difference in level of need is tested against an alternative hypothesis that there is a difference in 
need level proportions. A Fisher’s Exact test was used to assess differences if any group 
contained fewer than five subjects.  For information need subscales and items, the number of 
subjects reporting high information needs and the number reporting low needs with a group total 
is reported.  The proportion of those reporting high needs is reported with the proportion 
difference between the two groups (i.e. male high needs versus female high needs) and their 
associated 95% confidence intervals. The Chi-square test statistic, degree of freedom and p-value 
are also reported. If Fisher’s Exact Test was used then no test statistic is reported, only the p-
value. 
Logistic regression was used to test for a relationship between the continuous variable 
age and level of information needs.  Age was measured in whole years.  Participants were 
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indicated as having either high information needs or low information needs.  Age was 
summarized for each information need level with sample sizes, means, standard deviations, and 
confidence intervals.  Group high needs were summarized with frequencies and proportions.  
Parameter estimates, standard error, test statistics, p-values, and 95% confidence intervals are 
used to describe the change in odds of having high information needs due to a one-year increase 
in age.  Data were assumed normal and each observation is independent.  Linearity was assumed 
after the logit transformation.   
Information received. Like information needs, information received was also 
dichotomized into “high amount of information received” and “low amount of information 
received” The same statistical analyses (chi-square test for the binary variables gender and race 
and logistic regression for the continuous variable age) were also used to assess if information 
received levels (high and low) vary by demographics: gender, age, and race (Whites/non-
Whites). Pearson’s chi-square was used to assess the null hypothesis that proportion of high 
levels of received information for males is equal to the proportion of high levels of received 
information for females against the alternative hypothesis that the two groups’ proportions are 
different. The same analysis was conducted for proportions of received information for Whites 
and non-Whites. Logistic regression was used to test for a relationship between age and level of 
information received.    
RQ3: What sources do patients use to find information about their rare cancers?  Descriptive 
statistics were used to summarize the sources used by participants to find information about their 
rare cancers. The frequency and percentage of those who reported looking for information is 
described.  For each type of source (physician, print, Internet, friends, etc.) corresponding 
frequencies and percentages of patients reporting use are reported.  The data are listed in a 
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frequency distribution table that includes: each source; number of respondents reporting using 
each source; and percentage of respondents reporting using each source.   
RQ4: What sources do patients prefer when seeking information about their rare cancers?  
Descriptive statistics were used to summarize the data regarding preferred informational sources.  
For those who report searching for information, each type of source (physician, print, Internet, 
friends, etc.) is listed with the corresponding frequencies and percentages of source preferences 
reported by participants. The data are listed in a frequency distribution table that includes: source 
type; number of respondents reporting the source as preferred; and percentage of respondents 
reporting the source as preferred.   
RQ5: Are patients with rare cancers satisfied with the information they receive? 
Descriptive statistics were used to summarize the data regarding participant satisfaction for 
information they received. Frequencies and percentages for each category (“Yes” and “No”) for 
the questions, “overall were you satisfied,” “did you desire additional information, and “did you 
desire less information” are reported.  Perceived helpfulness, searching confidence, amount of 
effort to find information, frustration level, difficulty of information, concern about quality, and 
source trust are all reported on a Likert-type scale.  Frequencies and percentages for each 
response category are reported. For all questions, frequencies and percentages are listed in a 
distribution table with number of respondents for each category and percentages of patients 
reporting each.   
 Information satisfaction/dissatisfaction differences by gender, race and age are also 
reported.  A chi-square test was used to analyze differences in proportions of information 
dissatisfaction between males and females and to analyze differences between White and non-
White participants.  The frequency of reporting satisfaction and dissatisfaction are reported for 
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each group with the group totals, group portions reporting dissatisfaction, proportion differences 
and 95% confidence intervals, Chi-square test statistic, degrees of freedom and the p-value.  
Logistic regression was used to assess the relationship of age and information satisfaction. 
RQ6: Is information satisfaction related to perceived health-related quality of life? A t-
test was used to test the association between information satisfaction and perceived health-
related quality of life. A two-sample T-test was used to test the null hypothesis that the perceived 
health-related quality of life mean scores of patients reporting information satisfaction and those 
reporting dissatisfaction with information are equal. This was tested against a two-sided 
alternative hypothesis that the mean health-related quality of life scores is not equal between the 
two groups. Mean comparisons were conducted for both the physical health component scores 
and the mental health component scores of the SF-12 Health Related Quality of Life Measure. 
  Data are assumed normal using the Central Limit Theorem: n>30.  A Brown-Forsythe 
test was conducted to check for equal variances.  If variances were not equal a Welch’s test was 
used. Mean scores and standard deviations for the physical component of health-related quality 
of life and the mental health component are reported for both the information satisfied group and 
the dissatisfied group.  Differences between the means are reported with standard error, 95% 
confidence intervals, and p-value.   
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Chapter V. Results 
 
Survey Mailings 
Data collection began in October 2015 and was completed in May 2016. Table 2 below contains 
a timeline of letters and surveys sent and received. A total of 199 patients were identified as 
having a rare cancer and were asked to participate in the study via mailed survey. Letter 1 was 
mailed to a total of 199 patients identified as having a rare cancer. Letters 2 and 3 were mailed to 
all patients unless the patient or patient’s doctor contacted us opting out of the study or if a 
patient’s spouse contacted us informing us of the patient’s death. Letter 2 was sent to 197 
patients and Letter 3 was sent to 195 patients. Those not returning the completed survey and who 
had not opted out were then mailed follow-up letters.   Letter 4 was mailed to 68 patients and of 
those not responding, 48 were sent the final Letter 5.  
 Of the 199 surveys mailed to patients, 113 were returned resulting in a 56.7% overall 
response rate.  Six patients were reported as being deceased (3.0%), three surveys were returned 
as undeliverable (1.5%), and six patients opted out of participation (3.0%). Of the resulting 184 
eligible patients, 61.4% participated in the study.  
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Table 2. Letters and surveys sent and received 
Group 
#/Date of 
First 
Mailing 
Letter1  
# Sent 
Letter2 
# Sent 
Letter3 
#Sent 
Letter4 
#Sent 
Letter5 
#Sent 
Surveys 
Received 
Frequency, 
(%) 
Patients 
Deceased 
Returned as 
Undeliverable 
Requested 
to opt out 
of study 
Participation 
Rate 
Frequency 
( %) 
1 
(10/25/15) 
85 85 85 45 32 46 
(54.1%) 
3 3 2 46/77 
(59.7%) 
2 
(11/12/15) 
12 12 12 8 8 4 (33.3%) 0 0 0 4/12 
(33.3%) 
3 
(11/27/15) 
13 13 13 6 3 9 (69.2%) 1 0 0 9/12 
(75%) 
4 
(12/2/15) 
17 17 17 9 5 11 
(64.7%) 
0 0 1 11/16 
(68.7%) 
5 
(1/13/16) 
15 14 14 - - 8 
 (53.3%) 
1 0 1 8/13 
(61.5%) 
6 
(2/13/16) 
19 18 18 - - 10 
(52.6%) 
0 0 1 10/18 
(55.5%) 
7 
(2/29/16) 
25 25 24 - - 17 
(68.0%) 
0 0 1 17/24 
(70.8%) 
8  
(3/23/16) 
13 13 12 - - 8 (61.5%) 1 0 0 8/12 
(66.6%) 
TOTAL 199 197 195 68 48 113 
(56.7%) 
6 
(3.0%) 
3 
(1.5%) 
6 
(3.0%) 
113/184 
61.4% 
 
Demographics 
Socio-demographics of the sample are reported in table 3. Fifty-one respondents were 
male (45.1%) and 62 were female (54.9%).  The mean age of the sample was 59.0 years, 
(SD=15.90).  Of those responding, 69.9% self-identified as White/Caucasian, 25.7% as 
Black/African American, and 4.2% other races.  Less than 2% identified as Hispanic or Latino. 
The majority of the sample reported being retired (44.1%) and thirty-one participants (27.9%) 
reported working full-time. Twenty-one respondents (18.6%) reported a mean annual household 
income of greater than $100,000. Most participants reported having employee sponsored health 
insurance (40.7%) followed closely by Medicare coverage (32.7%). Appendix C contains tables 
listing participants’ cancer types, sites, and stages by demographics. 
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Table 3. Demographics 
n=113 Mean (SD) 
Age, Years  
 
59.0 (15.90) 
 
Gender 
Frequency (%) 
     Female 62 (54.9) 
     Male 51 (45.1) 
Race  
     Black or African American 29 (25.7) 
     White or Caucasian 79 (69.9) 
     Asian 1 (.89) 
     Native American or Alaska Native 0 (0) 
     Native Hawaiian/Pacific Islander 0 (0) 
     Multi-Racial 2 (1.8) 
     Other 2 (1.8) 
Hispanic or Latino Origin  
     Yes 2 (1.8) 
Employment Status (n=110)  
     Full-time paid 31 (27.9) 
     Part-time paid 11 (9.9) 
     Retired 49 (44.1) 
     Unemployed  13 (11.7) 
     Homemaker 6 (5.4) 
Medical Insurance Coverage (n=112)  
     None 3 (2.7) 
     Private insurance 14 (12.4) 
     Employer sponsored insurance 46 (40.7) 
     Self-pay 0 (0) 
     Medicare 37 (32.7) 
     State-sponsored insurance 1 (0.9) 
     Virginia Coordinated Care 1 (0.9) 
     Medicaid 7 (6.2) 
     Military 1 (0.9) 
     Not sure 1 (0.9) 
     Other 1 (0.9) 
Total Household Income (n= 108)  
     Less than $5,000 4 (3.5) 
     $5,001-$10,000 8 (7.1) 
     $10,001-15,000 6 (5.3) 
     $15,001-$20,000 5 (4.4) 
     $20,001-$25,000 2 (1.8) 
     $25,001-$30,000 6 (5.3) 
     $30,001-$40,000 5 (4.4) 
     $40,001-$50,000 14 (12.4) 
     $50,001-$60,000 9 (8.0) 
     $60,001-$70,000 12 (10.6) 
     $70,001-$80,000 9 (8.0) 
     $80,001-$90,000 2 (1.8) 
    $90,001-$100,000 5 (4.4) 
     Greater than $100,000 21 (18.6) 
 
 
 
 64 
 
Information Needs 
Below are the mean score results for each information need for the four information need 
subscales with scores for each of the items comprising the scale.  Table 4 shows each of the 
subscale scores’ means and standard deviations and each of the 23 items included in the 
information needs scale. Information need items are reported with respondent frequency and 
percentage reporting needs on a Likert scale from 1 (not at all) to 4 (very much). The Likert scale 
for each subscale and each item was converted into a 100-point scale called the scaled score. 
Scores for each are continuous ranging from 0 indicating low need to 100 indicating high 
information need.  
Information about disease. The mean information need score for the subscale, 
“information about disease” was found to be high at 74.62 (SD=23.8).  Four items comprise this 
subscale with the following mean level of information need: “diagnosis about your cancer” 
(M=79.0 SD=28.8); “the extent of your cancer” (M=72.4, SD=33.1); “the possible causes of 
your cancer” (M=64.8, SD=34.8); and “whether the cancer is under control” (M=81.8, SD=28.8).  
Information about medical tests. Participants had a high mean information need score 
for the subscale, “information about medical tests” (M=69.7, SD=28.9).  Three information need 
items comprise this subscale with the following mean level of information need: “the purpose of 
medical tests” (M=68.2, SD=33.0); “the procedures of the medical tests” (M=65.8, SD= 33.3); 
and “the results of the medical tests” (M=75.5, SD= 28.4).  
Information about treatment. The “information about treatment” subscale was also 
found to be high with a mean score of 64.8 (SD=26.31).  This subscale included six items. The 
mean information need scores for the items were: “treatment modality” (M=76.6, SD=32.0); 
“expected benefit of treatment” (M=80.0, SD=28.9); “possible side effects of treatment” 
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(M=75.7, SD=31.4); “expected effects of treatment on symptoms” (M=74.6, SD=34.2); “effects 
of treatment on social and family life” (M=51.4, SD=36.5); and “effects of treatment on sexual 
activity” (M=30.0, SD=37.8). 
Information about other services. The reported mean need score for the “information 
about other services” subscale was 33.1 (SD=29.3), which was comprised of four items. These 
items included: “additional help outside the home” (M=30.6, SD=34.9); “rehabilitation services” 
(M=27.9, SD=35.7); “aspects of managing illness at home” (M=47.4 SD=36.9); and “possible 
professional psychological support” (M=26.0, SD=33.4).  
Single items. There were two items that were single items in the information needs scale. 
“Different places of care” scored a mean level of information need of 40.4 (SD=38.2) and the 
other single item, “things you can do to help yourself get well” had a mean level of information 
need of 56.5 (SD=35.1). 
Added items. Four items were added to the existing information needs measure.  These 
included information need for: “the effects of treatment on fertility” (M=13.0, SD= 29.5);  “other 
treatment options” (M=53.3, SD=40.4); “financial/insurance resources” (M=48.2, SD=39.3); and 
“whether family members are at risk” (M= 49.2, SD=40.5). 
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Table 4: Information needs 
 
 
 Not at 
All 
A Little Quite a Bit Very 
Much 
Scaled Score  
(0 low – 100 
high)  
Mean (SD) 
 Frequency (%)  
Disease Subscale  74.6 (28.3) 
The diagnosis of your cancer (n=111) 4 (3.6) 16 (14.4) 26 (23.4) 65 (58.6) 79.0 (28.8) 
The extent of your cancer (n=110) 9 (8.2) 19 (17.3) 26 (23.6) 56 (50.9) 72.4 (33.1) 
The possible causes of your cancer (n=107) 10 (9.3) 31 (29.0) 21 (19.6) 45 (42.1) 64.8 (34.8) 
Whether the cancer is under control (n=110) 5 (4.5) 12 (10.9) 21 (19.1) 72 (65.5) 81.8 (28.8) 
Medical Test Subscale     69.7 (28.9) 
The purpose of any medical tests you have had 
(n=110) 
10 (9.1) 21 (19.1) 33 (30.0) 46 (41.8) 68.2 (33.0) 
The procedures of the medical tests (n=110) 9 (8.2) 29 (26.3) 28 (25.5) 44 (40.0) 65.8 (33.3) 
The results of the medical tests you have received 
(n=110) 
3 (2.7) 20 (18.2) 32 (29.1) 55 (50.0) 75.5 (28.4) 
Treatment Subscale     64,8 (26.3) 
The medical treatment (chemotherapy, radiotherapy, 
surgery, or other modality) (n=111) 
9 (8.1) 12 (10.8) 27 (24.3) 63 (56.8) 76.6 (32.0) 
The expected benefit of treatment (n=111) 7 (6.3) 7 (6.3) 32 (28.8) 65 (58.6) 80.0 (28.9) 
The possible side effects of the treatment (n=111) 10 (9.0) 8 (7.2) 35 (31.5) 58 (52.3) 75.7 (31.4) 
The expected effects of the treatment on cancer 
symptoms (n=109) 
13 (11.9) 8 (7.3) 28 (25.7) 60 (55.0) 74.6 (34.2) 
The effects of the treatment on social and family life 
(n=111) 
24 (21.6) 31 (27.9) 28 (25.2) 28 (25.2) 51.4 (36.5) 
The effects of treatment on sexual activity (n=108) 57 (52.8) 23 (21.3) 10 (9.3) 18 (16.7) 30.0 (37.8) 
Other Services Subscale     33.1 (29.3) 
Additional help outside the hospital (n=111) 51 (45.9) 32 (28.8) 14 (12.6) 14 (12.6) 30.6 (34.9) 
Rehabilitation services (n=110) 58 (52.7) 27 (24.5) 10 (9.1) 15 (13.6) 27.9 (35.7) 
Aspects of managing your illness at home (n=111) 29 (26.1) 31 (27.9) 26 (23.4) 25 (22.5) 47.4 (36.9) 
Possible professional psychological support (n=108) 
 
59 (54.6) 25 (23.1) 14 (12.9) 10 (9.3) 26.0 (33.4) 
Single Items      
Different places of care (n=109) 40 (36.7) 28 (25.7) 19 (17.4) 22 (20.2) 40.4 (38.2) 
Things that you can do to help yourself get well 
(n=111) 
16 (14.4) 35 (31.5) 27 (24.3) 33 (29.7) 56.5 (35.1) 
Added Items      
The effects of treatment on fertility (n=108) 87 (80.6) 8 (7.4) 5 (4.6) 8 (7.4) 13.0 (29.5) 
Other treatment options (n=109) 30 (27.5) 21 (19.3) 21 (19.3) 37 (33.9) 53.3 (40.4) 
Financial, insurance, work-related or legal resources 
(n=110) 
 
32 (29.1) 27 (24.5) 21 (19.1) 30 (27.3) 48.2 (39.3) 
Whether family members at risk for developing 
cancer (n=109) 
 
34 (31.2) 21 (19.3) 22 (20.2) 32 (29.4) 49.2 (40.5) 
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Information Received 
In addition to information needs, participants were also asked to report the amount of 
information they received for each informational item for which they reported information needs.  
Below are the mean score results for information received for the four information received 
subscales along with scores for each of the items comprising the scale.  Table 5 shows each of 
the 23 informational received items included in the scale along with respondent frequency and 
percentage reporting level of information received on a Likert scale from 1 (not at all) to 4 (very 
much). The Likert scale for each subscale and each item was converted into a 100-point scale 
called the scaled score. Table 5 also contains the mean scaled scores and standard deviations for 
each information received subscale and contains the scaled score and standard deviation for each 
information received items. Scores for the subscales and individual items are continuous ranging 
from 0 (low level of information received) to a score of 100 (high level of information received). 
Information about disease. The mean information received score for the subscale, 
“information about disease” was high at 62.1 (SD=26.9).  Four items comprise this scale with the 
following mean information received scores. The mean level of information received for the item 
“diagnosis about your cancer” was 73.6 (SD=27.4); “the extent of your cancer” was 65.2 
(SD=35.1); “the possible causes of your cancer” was 42.9 (SD=37.0); and “whether the cancer is 
under control” was 66.0 (SD=32.8).  
Information about medical tests. Participants’ mean information received score for the 
subscale, “information about medical tests” was also high at 72.8 (SD=25.4).  Three information 
received items comprised this subscale with the following mean level of information need: “the 
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purpose of medical tests” (M=71.2, SD=28.7); “the procedures of the medical tests” (M=71.5, 
SD=27.0); and “the results of the medical tests” (M=75.8 SD=27.1).  
Information about treatment. The mean received score for “information about 
treatment” subscale was 59.9 (SD=27.3).  This subscale included six items. The mean 
information received score for “treatment modality” (M=76.1, SD=28.4); “expected benefit of 
treatment” (M=71.5, SD=30.9); “possible side effects of treatment” (M=69.4, SD=34.0); 
“expected effects of treatment on symptoms” (M=65.5, SD=34.8); “effects of treatment on social 
and family life” (M=47.5, SD=36.2); and “effects of treatment on sexual activity” (M=27.5, 
SD=34.7). 
Information about other services.  The mean for the information received subscale, 
“information about other services” was low with a mean reported score of 32.36 (SD=26.892). 
Four items comprised this subscale of information received. These items included: “additional 
help outside the home” (M=27.6, SD=33.1); “rehabilitation services” (M=28.2, SD=35.0); 
“aspects of managing illness at home” (M=50.5, SD=34.2); and “possible professional 
psychological support” (M=23.6, SD=29.4). 
Single items. There were two items that were single items in the information received 
scale. “Different places of care” mean received score was 32.4 (SD=35.1) and the other item, 
“things you can do to help yourself get well” was found to have a mean score of information 
received of 56.2 (SD=35.9). 
Added items. Four items were added to the measure.  This included information received 
for: “the effects of treatment on fertility” (M=18.2, SD=31.6); “Other treatment options” 
(M=38.1, (SD=36.1); “financial/insurance resources” (M=35.8, SD=35.8); and “whether family 
members are at risk” was (M=32.4, SD=36.9).  
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Table 5: Information received  
 Not at All A Little Quite a Bit Very 
Much 
Scaled Score  
Mean (SD) 
 Frequency (%)  
Disease Subscale  62.1 (26.9) 
The diagnosis of your cancer (n=111) 4 (3.6) 16 (14.1) 44 (39.4) 47 (43.3) 73.6 (27.4) 
The extent of your cancer (n=110) 15 (13.6) 18 (16.4) 34 (30.9) 43 (39.1) 65.2 (35.1) 
The possible causes of your cancer (n=108) 33 (30.6) 33 (30.6) 20 (18.5) 22 (20.4) 42.9 (37.03) 
Whether the cancer is under control (n=104) 10 (9.6) 21 (20.2) 34 (32.7) 39 (37.5) 66.1 (32.8) 
Medical Test Subscale     72.8 (25.4) 
The purpose of any medical tests you have 
had (n=110) 
5 (4.5) 19 (17.3) 42 (38.2) 44 (40.0) 71.2 (28.7) 
The procedures of the medical tests (n=110) 1 (.90) 26 (23.6) 39 (35.5) 44 (40.0) 71.5 (27.0) 
The results of the medical tests you have 
received (n=110) 
 
2 (1.8) 19 (17.3) 36 (32.7) 53 (48.1) 75.8 (27.1) 
Medical Treatment Subscale     59.9 (27.3) 
The medical treatment (chemotherapy, 
radiotherapy, surgery, or other modality) 
(n=109) 
5 (4.6) 13 (11.9) 37 (33.9) 54 (49.5) 76.1 (28.4) 
The expected benefit of treatment (n=110) 8 (7.3) 16 (14.5) 38 (34.5) 48 (43.6) 71.5 (30.9) 
The possible side effects of the treatment 
(n=111) 
12 (10.8) 17 (15.3) 32 (28.8) 50 (45.0) 69.4 (34.0) 
The expected effects of the treatment on 
cancer symptoms (n=112) 
14 (12.6) 20 (18.0) 33 (29.7) 44 (39.6) 65.5 (34.8) 
The effects of the treatment on social and 
family life (n=108) 
27 (25.0) 31 (28.7) 27 (25.0) 23 (21.3) 47.5 (36.2) 
The effects of treatment on sexual activity 
(n=108) 
57 (52.8) 25 (23.1) 14 (13.0) 12 (11.1) 27.5 (34.7) 
Other Services Subscale     32.3 (26.8) 
Additional help outside the hospital (n=110) 
 
53 (48.2) 35 (31.8) 10 (9.1) 12 (10.9) 27.6 (33.1) 
Rehabilitation services (n=110) 56 (50.9) 29 (26.4) 11 (10.0) 14 (12.7) 28.2 (35.0) 
Aspects of managing your illness at home 
(n=111) 
21 (18.9) 35 (31.5) 32 (28.8) 23 (20.7) 50.5 (34.2) 
Possible professional psychological support 
(n=110) 
 
55 (50.0) 40 (36.4) 7 (6.4) 8 (7.3) 23.6 (29.4) 
Single Items      
Different places of care (n=112) 50 (44.6) 28 (25.0) 21 (18.8) 13 (11.6) 32.4 (35.1) 
Things that you can do to help yourself get 
well (n=111) 
18 (16.2) 33 (29.7) 26 (23.4) 34 (30.6) 56.2 (36.0) 
Added Items      
The effects of treatment on fertility (n=106) 73 (68.9) 17 (16.0) 7 (6.6) 9 (8.5) 18.2 (31.6) 
Other treatment options (n=106) 37 (34.9) 35 (33.0) 16 (15.1) 18 (17.0) 38.1 (36.1) 
Financial, insurance, work-related or legal 
resources (n=108) 
40 (37.0) 38 (35.2) 12 (11.1) 18 (16.7) 35.8 (35.8) 
Whether family members at risk for 
developing cancer (n=106) 
 
49 (46.2) 28 (26.4) 12 (11.3) 17 (16.0) 32.4 (36.9) 
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Unmet Information Needs  
Unmet information needs were assessed for information subscales and each of the 23 individual 
items. 
Information subscales. Unmet information needs (differences in information needs and 
information received) were calculated by computing scale scores for information needs and 
information received for each of the information needs and information received subscales 
(information disease, medical tests, treatment, other services) and the two single items (different 
places of care, and things you can do to help yourself get well). Greater mean scores indicate 
greater amounts of information needs or greater amounts of information received.  The scaled 
score means of information received was subtracted from information needs for each information 
subscale and for each individual information item.  A positive value indicates that information 
needs were greater than information received.  A negative value indicates a higher amount of 
information received than was needed.  
 Patients reported a high level of information needs for information about disease with a 
mean scale score of 74.6, however, reported an information received mean scale score of only 
62.1, resulting in a significant difference of 12.4 (p=0.0003).  No other information sub-scales 
were significantly different between information needs and information received. 
Unmet information needs for individual items.  In addition to differences in 
information subscale scores between information needs and information received, differences in 
all 23 individual items of information needs and received were assessed for differences.  There 
were significant differences in information needs among two information about disease subscale 
items where patients reported higher need than information received.  Patients reported high 
mean need (64.8) for information about possible causes of their cancer, but only reported 
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information received at a mean of (42.9), resulting in a significant difference of 21.9 (p<.0001). 
Patients also reported an unmet need for information about “whether their cancer is under 
control” with a difference of 15.79 (p=0.0306) and the added item, “whether family members are 
at risk for developing cancer” with a mean difference of 16.8 (p=0.0016).  
 Unmet needs were also reported in one treatment subscale item with patients needing 
more information than received about “the expected benefit of treatment” (difference=8.3, 
p=0.0388).  Patients desired more information than received about treatment options 
(difference=15.28, p=0.0037) an added treatment-related item.  Another added item, 
“information about financial, insurance, work-related or legal resources” also had a significant 
difference of 12.38 (p=0.0158). 
Information Need Differences by Demographics 
Chi-square and logistic regression analyses were conducted to assess the demographic 
differences in level (high need versus low need) for each of the information need sub-scales and 
all 23 information need items.  There were differences found in information needs by gender, 
race, and age.  
Information need scale differences by gender. For the subscale, “information about 
disease” there were gender differences in information needs.  Ninety-two percent of males 
reported high needs, whereas 76.6% of females reported high needs.  This resulted in a 
significant proportion difference of 15.4 (p=0.0378). There was also a significant difference in 
gender information needs in the subscale of “information about medical tests.” Males (84.3%) 
reported higher need than females (63.3%). This difference in proportions (20.9) was found to be 
significant (χ2=6.153, DF=1, p=0.0131). The only other significant difference in information 
needs by gender was “information needs about treatment.” Males (86.2%) reported high needs 
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and only 66.6% of females reported high needs resulting in a significant difference of 19.6 
(χ2=5.758, DF=1, P=0.0164).  
Information need item differences by gender. Gender differences in information need 
were seen for the “extent of your cancer (item in the information about disease subscale);” 
“purpose of medical tests (item in the information about medical tests subscale)” “expected 
effects of treatment on cancer symptoms (item in the treatment subscale);” and “different places 
of care (single item).” Forty-three males reported high information needs (86.0%) for the extent 
of cancer where 39 females reported high needs (65.0%), with a proportion difference of 21 
(95% CI [0.04, 0.35]).  Differences in need between males and females were found to be 
significant (χ2=6.334 df=1, p=0.0118). Males (82.4%) and females (62.7%) reported high 
information needs for the purpose of medical tests, with males reporting a higher proportion 
difference of 19.6 (95% CI [0.02, 0.34]) in need which was found to be significant (χ2=5.214 
df=1, p=0.0224). 
 Males had significantly higher levels of need for other items, with 90% of males 
reporting high needs for the “expected effects of treatment on cancer symptoms” and 72% of 
females reporting high needs for the same item (χ2=5.099, df=1, p-value=0.0239). There was a 
21.4 difference in proportions of high needs for “different places of care,” with males having a 
significantly higher level of need (χ2=5.313, df=1, p-value=0.0212). 
Information need scale differences by race: None of the information scales showed a 
significant difference in race (Whites and non-Whites), although there were race differences 
between Whites and non-Whites, with Whites reporting less information need than non-Whites 
for specific items. For Whites, the mean level of information need for “aspects of managing your 
illness at home” was 38.4 and for non-Whites 60.6, with a significant proportion difference of 
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22.2 (χ2=4.594 df=1, p=0.0321). For Whites the mean level of need for “effects of treatment on 
sexual activity” was 19.7 and for non-Whites 43.7, resulting in a significant proportion 
difference of 24.0 (χ2=24.013 df=1, p=0.00101). 
Information need scale differences by age: Older age proved significant for higher 
levels of information need of the subscale, “information about disease.” The mean age for high 
needs for this subscale was 60.7 (SD=14.9, 95% CI [57.63, 63.76]) whereas the mean age for 
low needs was 49.4 (SD=18.3, 95% CI [40.27, 58.50]). For every one-unit increase in age, the 
odds of having high needs for “information about disease” increase by 0.04 (χ2=7.00, DF=1, 
p=0.0082).  
Information need item differences by age: Age proved significant for high information 
needs for information for two items in the information about disease subscale: “cancer extent;” 
and “whether the cancer is under control.” The mean age of high needs (82.0%) was 60.7 years 
and for low needs (28.0%) the mean age was 52.9 (SD=14.0, 95% CI [57.64, 63.84]. A one-unit 
increase in age increases the odds of having high information needs for “the extent of cancer” by 
1.03 (χ2=4.85, df=1, p=0.0277). The mean age of patients reporting high levels of information 
need for “whether the cancer is under control” was 60.3 and the mean age reporting low needs is 
49.6.  The odds of having high information need for this item increase by 1.04 for each unit 
increase in age (χ2=6.04 df=1, p=0.0124). 
There were also age differences in information needs in three items included in the 
“information about medical tests” subscale: the “purpose of the medical tests;” “the procedures 
of the medical tests,” and “the results of medical tests.” The mean age reporting high needs for 
the purpose of medical tests was 60.7 and the mean age reporting low needs was 53.4.  The odds 
of having higher needs for the purpose of medical tests was 1.02 greater for each one-unit 
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increase in age. (χ2=4.16, p=0.0413). The mean age of patients reporting high levels of 
information need for “procedures of the medical tests” was 61.1 and the mean age reporting low 
needs was 54.4.  The odds of having high information received for this item increase by 1.026 
for each unit increase in age (χ2=4.19 df=1, p=0.0405). The mean age of patients reporting high 
levels of information need for “results of medical tests” was 61.2 and the mean age reporting low 
needs is 49.9.  The odds of having high information need for this item increase by 1.04 for each 
unit increase in age (χ2=8.20 df=1, p=0.0042). 
High information needs also significantly increased with age for the item, “the expected 
benefit of treatment” which is an item in the treatment subscale.  The mean age of patients 
reporting high levels of information need for “expected benefit of treatment” was 60.3 and the 
mean age reporting low needs is 48.6.  The odds of having high information need for this item 
increase by 1.045 for each unit increase in age (χ2=6.15 df=1, p=0.0132). 
 Information needs significantly decreased with age for “the effects of treatment on 
sexual activity (an item included in the treatment subscale),” and “the effects of treatment on 
fertility.” The mean age of patients reporting high levels of information need for “the effects of 
treatment on sexual activity” was 53.3 and the mean age reporting low needs is 60.3.  The odds 
of having high information need for this item decrease by 0.972 for each unit increase in age 
(χ2=4.01 df=1, p=0.0451). The mean age of patients reporting high levels of information need for 
“effects of treatment on fertility” was 40.8 and the mean age reporting low needs is 61.1.  The 
odds of having high information need for this item decrease by 0.91 for each unit increase in age 
(χ2=14.22 df=1, p=0.0002). 
Information received differences by demographics. Information received levels 
(high/low) were also assessed for each of the information received subscales and all 23 
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information received items to assess if information received varied by demographics. Chi-square 
and logistic regression analyses showed that information received items varied by the 
demographics of gender, race, and age.  
Information received scale differences by gender: There were no differences in any sub-
scales by gender, although there were significant item differences in the level of information 
received about the “medical treatment modality (an item in the information about treatment 
subscale)” between males and females.  Ninety-two percent of males reported receiving high 
levels of information received about “medical treatment” as compared to only 76.3% of females 
reported high levels, resulting in a significant difference of 15.3 in proportions between the two 
groups using Fisher’s Exact Test (p=0.0376). There were no other significant differences by item 
in this subscale. 
Information received scale differences by race: There were no differences in any of the 
information received sub-scales by race, however, there were differences in an individual item. 
There were differences between information received about “the extent of your cancer” (an item 
in the information about disease subscale) between Whites and non-Whites with Whites 
reporting receiving more information than non-Whites. Fifty-six percent of non-White 
participants reported receiving high levels of information about “the extent of their cancer” as 
compared to 76.3% of Whites.  This difference of 20.4 in proportions was a significant 
difference in information received between the two groups (χ2=4.670, DF=1, p=0.0307). There 
were no other significant differences by item in this subscale. 
 Information received scales by age: There was a significant difference in age for the 
information received scale, “information about other services.” The mean age for having high 
level of information received for the scale was 51.6 (SD=15.6, 95% CI [45.08, 58.03]) and the 
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mean age for low level of information received was 61.1 (SD=15.4, 95% CI [57.77, 64.38]). For 
every one-unit increase in age, information received for information about other services 
decreases by 0.03 (χ2=6.52, DF=1, p=0.0106). 
Information received item differences by age: Information received levels varied by age 
for three items.  There were lower levels of information received for “effects of treatment on 
sexual activity (an item in the information about treatment subscale)” and also the “effects of 
treatment on fertility (an added single item).”  Information received for both of those items 
decrease with older age.  The mean age reporting high received for the “effects of treatment on 
sexual activity” is 49.2 and the mean age reporting low received is 61.7.  The odds of having 
received high levels of information about this item decreased by 0.95 for each unit increase in 
age (χ2=10.68 DF=1, p=0.0011). Likewise, the odds decrease by 0.95 for each unit increase in 
age for the information received about “the effects of treatment on fertility (χ2=7.33, df=1, 
p=0.0). 
 Levels of information received also differed by age for the “other services” subscale item, 
“additional help outside the home.”  The mean age for high levels received for this item was 60.7 
years and for low levels received the mean age was 51.5.  Being an older age was significant for 
higher levels of information received for this item.  For each one-unit increase in age, the odds of 
receiving higher levels of information about additional help outside the home increased by 1.04 
(χ2=5.52, df=1, p=0.0188) 
Information Sources 
 
 Sources sought. Participants were asked to select all sources where they seek health 
information from a list of 12 various sources.  Source types to choose from included: books, 
brochures, cancer organizations, friends, doctor, Internet, library, magazines, newspapers, 
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telephone information number, and complementary medicine sources. Participants were also 
asked to specify whether they sought information from any other sources and, if so, they were 
prompted to list them.  Out of 112 participants responding to the question, nearly all (93.8%) 
reported searching for health information from any source.  The most sought source for 
information was the Internet (n=89, 80.9%), followed by doctor or health care provider (74.5%).  
Over a third of participants (n=43) reported using cancer organizations (39.1%) as a source for 
finding information and seeking information and 36.3% reported receiving information from 
brochures and pamphlets.  The least reported sources of information for health information were 
complementary and alternative medicine (3.6%) and telephone information hotlines, with only 
two participants (1.8%) reporting using this channel to seek information. A complete list of all 
sources participants used to search and the frequency of reported use is found in Table 6.  
 Sources preferred. Participants were also asked to select one preferred choice of 
information from the same list of sources from which they sought information.  The majority of 
the sample (n=91) reported preferring their “Doctor or health care provider (80.5%)” as a source 
for information, followed by Internet (23.0%) and cancer organizations (17.7%). The least 
preferred sources for health information were magazines, newspaper, telephone information 
numbers, library, and friends/co-workers, with less than 2% of participants preferring each of 
these.  No participants reported preferring complementary alternative, or unconventional 
practitioners as a source of information. Participants’ health information source preference 
frequencies and percentages are found in Table 6.  
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Table 6: Sources preferred and used for information 
 
 
Preferred Source 
(n=113) 
Sources Used 
(n=112) 
Sources Frequency (%) Frequency (%) 
Doctor or health care provider 91 (80.5) 82 (74.5) 
Internet 26 (23.0) 89 (80.9) 
Cancer organization 20 (17.7) 43 (39.1) 
Brochures, pamphlets, etc. 9 (8.0) 40 (36.3) 
Books 5 (4.4) 17 (15.5) 
Family 3 (2.7) 35 (31.8) 
Friend/Co-Worker 2 (1.8) 28 (25.5) 
Magazines 2 (1.8) 16 (14.5) 
Other 2 (1.8) 1 (.90) 
Library 1 (.89) 10 (9.1) 
Newspapers 1 (.89) 8 (7.3) 
Telephone information number 1 (.89) 2 (1.8) 
Complementary, alternative, or unconventional 
practitioner 
0 (0.0) 4 (3.6) 
 
Information Satisfaction 
In addition to participants’ information satisfaction, questions assessed perceived helpfulness of 
the information they received about their rare cancer.  Two questions assessed whether 
participants desired additional information and an open-ended question asked what additional 
information they desired.  Questions also assessed the participants’ self-confidence finding 
health information about their condition and their perceived level of difficulty in finding and 
receiving the information to fill their information needs.  Finally, participants’ trust in the health 
information sources was also assessed.   
Overall information satisfaction. Participants’ general information satisfaction was 
assessed with the question, “Overall, were you satisfied with the information you received about 
your rare cancer?”  with a yes/no response. While the majority of participants (81.1%) reported 
being satisfied with the information they received about their rare cancer, 21 participants 
(18.9%) reported dissatisfaction. Even though the majority reported being satisfied with the 
information they received, 46 participants (43.0%) reported they desired additional information 
 79 
 
about their conditions, while only 4 participants (4.3%) desired receiving less information. 
Information satisfaction data can be found in Table 7 below. 
Table 7: Overall information satisfaction 
 Yes 
N (%) 
No 
N (%) 
In general, were you satisfied with 
the information? 
N=111 
90 (81.7) 21 (18.9) 
Did you desire additional 
information? 
N=107 
46 (43.0) 61 (57.0) 
Did you desire less information? 
N=92 
4 (4.3) 88 (95.7) 
 
Information satisfaction by demographics. Information satisfaction by demographics 
can be found in Table 8 below. Information satisfaction was not found to be significantly 
different between race (White/non-White) and was not found to be significantly different due to 
age.  There was, however, a significant difference between the proportion of males and females 
who reported dissatisfaction with the information they received.  Ten percent of males were 
dissatisfied with information received, whereas 25.8% of females reported dissatisfaction.  The 
difference in these proportions of 15.6 was found to be significantly different (χ2=4.343, df=1, 
P=0.0372).  
Table 8: Information satisfaction differences by demographics 
Demographic 
 
Information Satisfaction 
 
Satisfied       Dissatisfied  
 
 
n 
Proportion 
reporting 
dissatisfaction 
 
Proportion difference  
(95% CI) 
 
Chi-Square 
DF=1 
 
 
P-value 
Gender 
Male 
  Female 
 
44                     5 
46                     16                 
 
 
49 
62 
 
10.2 
25.8 
-15.60 
[-0.28, -0.00] 
 
4.343 
 
0.0372* 
Race 
              White 
              Non-White 
 
64                     13 
26                     8 
 
77 
34 
 
16.8 
25.5 
 
6.66 
[-0.09, 0.23] 
 
0.679 
 
0.4099 
 
Age                        N         mean age (SD) 
Satisfied        90          54.5 (16.3) 
Dissatisfied   21          61.3 (14.3) 
 
95% CI [55.02, 61.88] 
95% CI [54.81, 67.85] 
Parameter Estimates 
Term             Estimate         Std. Error       ChiSquare      Prob>ChiSq        Odds Ratio     95% CI   
Intercept        -2.1617716       0.994           4.73                0.0296               1.01186        [0.981, 0.988] 
Age               0.01179059       0.015           0.55                0.4502        
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Perceived helpfulness of information. Participants’ perceived helpfulness of the 
information they received was also assessed using one question, “How helpful was the 
information?” Response categories were on a four-point Likert scale anchored with “not at all” 
on one end and “very much” on the other.  The majority of the participants (81.5%) responded 
with “quite a bit” or “very much” to the question, while only 19 participants reported that the 
information they received was not at all helpful (0.9%) or only “a little’ helpful (17.5%). 
Perceived helpfulness of information can be found in Table 9 below. 
Table 9: Perceived helpfulness of information 
 Not at All 
N (%) 
A Little 
N (%) 
Quite a 
Bit  
N (%) 
Very Much 
N (%) 
How helpful was the information? 
N=103 
1 (0.97) 18 (17.5) 37 (35.9) 47 (45.6) 
 
 Searching confidence. Participants’ self-confidence in their ability to obtain information 
was assessed with the question, “Overall, how confident are you that you could get advice or 
information about health or medical topics if you needed it?”  Responses were on a five-point 
Likert scale anchored on one end with “completely confident” and on the other end, “not 
confident at all” and can be found in Table 10 below. Overall, the majority of the sample 
reported being confident in finding information about their rare cancer.  Thirty-two participants 
(28.6%) reported being completely confident and 43 participants (38.4%) reported being very 
confident in their ability to obtain health information.  Thirty participants (26.8%) reported being 
only somewhat confident, five participants reported being only a little confident (5.4%), and one 
participant (0.9%) reported being, “not at all” confident in their ability to find health information. 
Table 10: Searching confidence 
 Completely 
N (%) 
Very 
N (%) 
Somewhat 
N (%) 
A Little 
N (%0 
Not at 
All 
N (%) 
How confident are you that you could 
get advice or information? (n=112) 
32 (28.6) 43 (38.4) 30 (26.8) 6 (5.4) 1 (.90) 
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 Amount of effort to find information. The amount of effort perceived to find 
information was assessed by having participants respond to how much they agree with, “It took a 
lot of effort to get the information you needed.” Responses were on a four-point Likert scale 
anchored on one end with “strongly agree” and “strongly disagree” on the other end. Although 
the majority of the participants (67.0%) reported having confidence in their ability to obtain 
information, 47 participants (44.0%) responded they “strongly agree (17.8%)” or “somewhat 
agree (26.2%)” it took a lot of effort to obtain the information they needed. 
 Level of frustration in finding information. Nearly half (44.4%) of the participants also 
reported a level of frustration finding information.  Participants were asked to respond on a four 
point Likert scale from “strongly agree” to “strongly disagree” to the question “You felt 
frustrated during your search for information.” Twenty-one participants reported they “strongly 
agree (19.4%)” and 27 participants reported they “somewhat agree (25.0%)” they were frustrated 
during their search for the information.  
 Difficulty understanding information found.  Participants reported on a four point 
Likert-type scale from strongly agree to strongly disagree to the question, “The information 
found was hard to understand” to ascertain participants’ difficulty understanding the information 
they received.  Although not a majority, nine participants responded they “strongly agreed 
(8.3%)” and 34 “somewhat agreed (31.5%)” that the information found was difficult to 
understand.  
 Quality of Information. Participants were asked to report their level of concern about 
the quality of information received with the stem question, “You were concerned about the 
quality of the information.”  Question response format was on a four point Likert scale anchored 
by “strongly agree” on one end and “strongly disagree” on the other end. Responses were mostly 
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evenly distributed with 27 participants responding, “strongly agree (25.0%)” and 28 participants 
responding, “somewhat agree (25.9%).” About half of the respondents reported, “somewhat 
disagree (25.0%)” or “strongly disagree (24.1%).” Search effort, frustration with finding 
information, understanding of information, and information quality can be found in Table 11 
below.  
Table 11: Search effort, frustration, understanding, and information quality 
 Strongly 
Agree 
N (%) 
Somewhat 
Agree 
N (%) 
Somewhat 
Disagree 
N (%) 
Strongly 
Disagree 
N (%) 
It took a lot of effort to get the 
information you needed (n=107) 
19 (17.8) 28 (26.2) 36 (33.6) 24 (22.4) 
You felt frustrated during your search 
for the information (n=108) 
21 (19.4) 27 (25.0) 25 (23.1) 35 (32.4) 
The information found was hard to 
understand (n=108) 
9 (8.3) 34 (31.5) 41 (40.0) 24 (22.2) 
You were concerned about the quality 
of the information (n=108) 
27 (25.0) 28 (25.9) 27 (25.0) 26 (24.1) 
 
 
Source Trust. As reported above, approximately 50% of participants were concerned 
about the quality of the information they received. Participants were also asked to rate their trust 
in sources.  Sources they were asked to rate included: doctor, family or friends, newspaper or 
magazines, radio, Internet, television, government health agencies, charitable organizations, and 
religious organizations and leaders. Participants’ reported trust in sources can be found in Table 
12 below. Responses were on a four point Likert-scale anchored by “not at all” on one end and 
“a lot” on the other end.  More than any other source, participants reported trusting their doctor. 
Eighteen participants (15.9%) reported trusting their doctor “some” and 93 participants (82.3%) 
reported they trust their doctor as a source of information “a lot.” Following trust of doctors was 
participants’ trust in the Internet, with 58 participants reporting “some” (53.2%) trust and 20 
reporting, “a lot” (18.4%) of trust. Other reported trusted sources of information are government 
health agencies and charitable organizations, with 66 participants reporting “some” (44.5%) or “a 
lot” (15.5%) of trust for government agencies and 57 participants reporting “some” (44.5%) or “a 
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lot” (7.2%) of trust for charitable organizations. The least trusted sources reported by the sample 
were radio, with 91 participants reporting “not at all” (46.2%) or “a little” (40%) trust and 
television, with 44 participants (40.7%) responding “a little” and 36 participants (33.3%) 
reporting “not at all.”  
Table 12: Trust in information sources  
Frequency (%) Not at All A Little Some A Lot 
Doctor (n=113) 0 (0.0) 2 (1.8) 18 (15.9) 93 (82.3) 
Internet (n=109) 6 (5.5) 25 (22.9) 58 (53.2) 20 (18.4) 
Government health 
agencies (n=110) 
17 (15.5) 27 (24.5) 49 (44.5) 17 (15.5) 
Family or Friends 
(n=110) 
16 (14.5) 37 (33.6) 48 (43.6) 9 (8.2) 
Charitable 
organizations (n=110) 
23 (20.9) 30 (27.2) 49 (44.5) 8 (7.2) 
Religious 
organizations and 
leaders (n=108) 
38 (35.2) 35 (32.4) 30 (27.8) 5 (4.6) 
Television (n=108) 36 (33.3) 44 (40.7) 27 (25.0) 1 (.92) 
Newspaper or 
magazines (n=110) 
20 (18.2) 49 (44.5) 41 (37.2) 0 (0.0) 
Radio (n=108) 50 (46.2) 41 (40.0) 17 (15.7) 0 (0.0) 
 
Health-Related Quality of Life  
Health-related quality of life was assessed using the SF-12 and was scored using scoring 
software.  Scores are norm-based with a norm mean of 50 (SD=10.0) and range from 0 to 100.  
Higher scores indicate better health for both the physical health component and the mental health 
component, where lower scores indicate worse health for both physical and mental components. 
The overall health-related quality of life physical health mean component score for the sample 
was M=40.0 (SD=11.6) and the mean mental health component score for the sample was 
M=49.6 (SD=9.7). Health-related quality of life scores and information satisfaction can be found 
in Table 13 below. 
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Information Satisfaction and Health-Related Quality of Life 
Two-sided t-tests were used to compare health-related quality of life (physical health component 
and mental health component) scores between the information satisfied group and the 
information dissatisfied group.  The mean physical health component score for the information 
satisfied group was M=39.8 (SD=11.7) and the mean physical health component for the 
information dissatisfied group was M=41.0 (SD=10.9). A difference of -1.2 (SE=2.8, 95% CI [ -
6.93, 4.48] between the two groups was shown not to be significant (t106=0.42485, p=0.6718).  
Likewise, the 1.2 difference (SE=2.4, 95% CI [-3.51, 6.10] between the information satisfied and 
information dissatisfied groups’ mental component score was found to not be significant 
(t106=0.5335, p=0.5948). 
 
Table 13: Information satisfaction and health-related quality of life 
 All Participants 
HRQL Score 
(SD) 
n=111 
Information 
Satisfied Group 
HRQL Score (SD) 
n=88 
Information 
Dissatisfied Group 
HRQL Score (SD) 
n=20 
Group 
Difference 
SE 
[95% CI] 
t (DF) p-value 
Physical 
Component 
Scale 
(0-100) 
(PCS) 
40.091 
(11.645) 
39.894 (11.776) 41.067 
(10.901) 
-1.223 
2.879 
[-6.932, 
4.485] 
 
-0.42485 
(106) 
 
0.6718 
Mental 
Component 
Scale 
(0-100) 
(MCS) 
49.69 
(9.704) 
49.949 
(9.700) 
48.655 
(10.171) 
1.293 
2.424 
[-3.513, 
6.100] 
0.5335 
(106) 
0.5948 
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Chapter VI. Discussion 
 
Information Needs and Information Received 
This study aimed to fill an important gap in the literature by identifying the types of cancer-
related health information that patients diagnosed with rare cancers need in order to improve 
information provision to this often over looked population. In addition to identifying the needs of 
patients with rare cancers, this study also explored the levels of health information patients 
reported receiving.  Owing to noted discrepancies in reported information needs and information 
received, gaps were subsequently examined to identify unmet needs in this population in order to 
gain further insight into ways to meet the information needs of patients with rare cancers. 
Information needs. Participants in this study had high needs for most subscales and items 
and very high needs were reported for subscales “information about disease,” “information about 
medical tests,” and “information about treatment.” Specifically, participants had very high needs 
for the individual items, “whether the cancer is under control,” and “the expected benefit of 
treatment.” These categories of information, particularly “information about disease” and 
“information about treatment” are cancer-specific types of information, which are more difficult 
to find and obtain than other subscale information such as “information about other services.”  
This is particularly true for rare cancers where there may be very little consumer-level cancer-
specific information available.  These high reported needs demonstrate the importance for 
information provision of cancer specific information to patients with rare cancers.  While most 
needs were high, participants in this study reported lower need for “information about other 
services” and single subscale item, “different places of care.” These reported lower needs may be 
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a reflection of where patients are in their health care journey and only a small sub-set of patients 
may need access to other services or other places of care. While these needs are reported as low, 
health-care providers should still be cognizant of patients who may need access to this type of 
information.   
Similar to participants with rare cancers in this study, studies of general cancer patients 
show that cancer-specific information is reported as a high need. General cancer patients report 
desiring to learn more about their specific cancer type including etiology, physical effects, 
diagnosis, and symptoms (Rutten et al., 2005).  Likewise, general cancer patients also report high 
need for treatment-related information including specific cancer treatment and treatment options 
(Maddock et al., 2011) similar to the high levels of need found in patients this study of patients 
with rare cancers, emphasizing the continued importance of information provision to patients 
with general and rare cancers.  
Information received. Participants reported high levels of information received for the 
subscale “information about medical tests,” and moderately high levels of information received 
for “information about disease,” and “information about treatment.” This moderate to high level 
of information received reported demonstrates that healthcare providers are delivering high 
levels of information and most likely directing patients to other sources of information about 
their rare cancer.  This also demonstrates that this level of information provision should be 
maintained.   
Information needs/received by demographics. This study showed that information 
needs and information received varied by demographics, specifically by gender, race and age. 
There were differences in information needs and information received between males and 
females, Whites and non-Whites, and by age.  These gender, age, and race differences in 
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information needs can inform healthcare providers and information professionals so they can 
tailor information for specific demographic groups based upon greater identified need.  These 
demographic differences can also help inform website development when creating web portals of 
information about rare diseases so specific demographic groups can be targeted and provided 
with potentially needed types of health information.  
Gender. One surprising finding from this study is that men reported having significantly 
higher levels of information need for the scales: information about “disease,” “medical tests,” 
and “treatment,” and also many information items including the “extent of cancer,” “the purpose 
of medical tests,” “expected effects of treatment on symptoms,” and “different places of care.”   
This number of differences demonstrates that in some circumstances males have higher 
information needs. This finding was so surprising that the researcher verified that the coding of 
gender of participants had not been inadvertently switched anywhere throughout the process.  
The research literature of the information needs of general cancer patients demonstrates 
information needs vary by gender, with females reporting higher levels of information need than 
men (Rutten, 2005, 2006).  Females also report needing general cancer site information and 
psychological support at a higher level than men, whereas men report higher treatment 
information needs (Rutten, 2006). The findings of this study conflict with gender differences of 
information need found in studies of general cancer patients. 
Not only do females report higher levels of information need for cancer information, 
research studies show that females are more likely to have higher information need in other non-
cancer areas of health (Tong, Raynor, & Asiani, 2014; Ek, 2013; and Manierre, 2015).  Very few 
studies have been conducted to assess the reasons gender based discrepancies exist in health 
information needs.  Few theories exist that may explain gender differences but one theory is 
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gendered perceived risk of illness (Manierre, 2015).  If men do not perceive a high risk or threat 
from their condition, they may not be motivated to seek information. Men diagnosed with rare 
cancers, as in the case of this study, may have a higher perceived risk due to the fact that their 
cancer is considered rare.  One concept in Johnson’s Comprehensive Model of Cancer 
Information Seeking is perceived risk and increased perceived risk is a motivational factor of 
searching for information.   
For healthcare information provision, this finding of higher information need among 
males is important.  Healthcare providers and information professionals may need to be 
cognizant that with rare cancers, males may desire more information.  Given the fact that this 
finding of greater information needs for males is very different from other research on general 
cancers, more research on the information needs of patients with rare cancers should be 
investigated. Interestingly, although men in this study reported higher information needs, females 
actually reported a higher level of dissatisfaction with information provision than did males in 
this study which should also be further explored in future studies. 
Men reported higher need for many information items, however, there was only one item 
where males received higher levels of information.  Specifically, males reported receiving more 
information about “medical treatment” than females.   
Race. This study found that Whites and non-Whites in this population largely needed and 
received the same levels of information for most information items, however, there are 
differences in needs for two information need items and one received item.  Non-Whites have 
greater information needs for “aspects of managing your illness at home” and “effects of 
treatment on sexual activity.” Whites reported receiving more information than non-Whites for 
only one item, “the extent of your cancer.” 
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Likewise, a study by Asare, Peppone, Roscoe, et al (2016) of patients diagnosed with 
general cancers found there were information need differences between Whites and Blacks.  
Blacks reported needing significantly more information about cancer tests, follow-up, healthy 
living, stress management, and handling stigma.   
Being cognizant of these differences of information need by race can help healthcare 
professionals be more proactive in providing information.  The information need differences 
between race found in this study allow providers to target specific racial groups with tailored 
health information that will meet their identified information needs.  
Age. The research literature also shows there are age differences in information needs, 
with older individuals reporting higher needs for information about treatment and younger 
individuals most likely to report higher needs for information about general cancer (Rutten, 
2006). Rutten (2006) examined informational needs of cancer patients who actively seek cancer 
information by socio-demographic status using 2003 HINTS survey data and found that younger 
cancer patients were more likely to seek health information than those who are sixty-five or 
older.   
 This study also found significant age differences in information need items.  The 
likelihood of reporting high needs for, “whether the cancer is under control, “the procedures of 
the medical tests,” “the results of the medical tests,” and “expected benefit of treatment” 
increased with age.  This study found that younger age was significant for higher needs about 
“effects of treatment on sexual activity,” and “the effects of treatment on sexual activity.” Also, 
younger participants in the study reported receiving this information at higher levels than older 
participants. The likelihood of reporting high needs for the subscale “information about other 
services” and the “information about other services” subscale item, “additional help outside the 
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home” increased with age. Being aware of information differences in needs and received for 
patients with rare cancers can help providers tailor information for younger and older patients so 
that needs can be met for all age groups.  
Participants in this study of all demographics (gender, race, and age) report high levels of 
need and received information, however, a minority of the participants report being dissatisfied 
with the information they received. This prompted the researcher to explore where there were 
unmet needs. Identifying unmet needs provides additional information where information 
provision should be increased.   
Unmet Information Needs 
Although analyzing unmet information needs was not part of the research aims of this study, the 
findings are intriguing. The unmet needs found in this study provide clarification regarding how 
provision of information to patients with rare cancers should be improved. Examining the unmet 
needs found in this study (information need scores greater than information received scores) for 
the information sub scales, the largest and statistically significant unmet need was found in 
“information about the disease.” This unmet information need is not surprising in the population 
of patients diagnosed with rare cancers. The literature shows that patients with rare diseases and 
general cancers often express specific disease information as an important need, but report it is 
often unmet.  For example, Anderson et al. (2013) reported that patients with rare diseases were 
dissatisfied with their diagnosis experience.  One of the reasons they reported dissatisfaction was 
that they did not receive adequate information about their specific rare disease.  A study 
conducted by Shea-Budgell, Kosarus, Myhill, & Hagan (2014) about information needs of 
patients with general cancers found that 43% reported searching for information on their specific 
cancer type.   
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All other information needs and received scale comparisons were not shown to be 
statistically significant for unmet needs.  This may be due to the fact that more information is 
available about each of these information types because most would be the same types of 
information given to patients diagnosed with general cancers.  For example, information about 
different places of care, other services, and things you can do to help yourself get well may be 
easier to obtain because they are general and not disease-specific informational items.   
Disease information items: Participants in this study of patients with rare cancers 
reported unmet needs in two particular disease information items. Patients reported high 
information needs for etiology (possible causes of their cancer) and whether the cancer is under 
control. Given that little is known about many rare cancers, cancer etiology may not be known or 
may be very difficult information to locate.  For example, one rare cancer, Multicentric 
Castleman Disease has no known cause.  While there are many recent theories as to the etiology 
of the disease, currently it is unknown.  Patients or their healthcare providers would have to 
search the current medical literature to assess the current theories of the etiology of Castleman 
Disease and for any other rare cancers where etiology is unknown.  
Treatment information items: Two treatment need items were shown to be unmet in 
this study: “other treatment options (an added item),” and “the expected benefit of treatment.”  
Treatment information has been found to be very important among patients diagnosed with 
general cancers.  Treatment information was reported as the most important type of information, 
more than any other information need in a study by Shea-Budgell, et al. (2014).   
In addition to desiring information about specific treatment options offered by their own 
physician, patients also desire information about all treatment options available for their 
conditions (Castleton, Fong, Wang-Gillam, Waqar, & Jeffe, 2010).  Many rare cancers have few 
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treatment options available. This may be one reason why patients may experience difficulty 
finding treatment information about specific rare diseases.  Likewise, there may be a lack of 
knowledge regarding treatment options among many oncologists who do not see many patients 
with any particular type of rare cancer, especially very rare cancers. Treatment option 
information may also be difficult to find if treatments are very new and may only be found in the 
latest medical literature.   
Likewise, the “expected benefit of treatment” may not be fully known, particularly for 
many rare cancers.  These cancers often do not have specific United States Food and Drug 
Administration (FDA) approved treatments and off-label treatments may be used to treat a rare 
cancer.  For example, oncologists may treat a rare cancer with a drug that is approved for use in 
another related type of cancer, basing treatment options on a few case studies found in the 
research literature.  There is little research showing expected outcomes of treatment with these 
drugs for the particular rare cancer because no randomized controlled trials have been conducted 
for many rare cancers. Benefits may be largely unknown resulting in patients having unmet 
needs about the benefits of treatment.   
Financial, insurance, work-related, and legal resources information item: The only 
other statistically significant item where an unmet information need was found was the added 
item regarding financial, insurance, work-related, or legal resources information needs.  
Interestingly, this was the only item of information need found to be significantly unmet that 
would be considered not applicable to a specific cancer. For example, this type of information 
can be answered with general informational resources.  Though reported needs for this item were 
at a moderate level, information received was reported as very low compared to need.  
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Financial, insurance, work-related, and legal resources information may be particularly 
important for the rare/genetic disease population due to many significant barriers throughout 
their healthcare journey (Schaefer, 2012) which may lead to greater financial burden, insurance, 
and work-related issues.  These patients may require more tests to diagnose their condition, need 
to travel long-distances to an oncologist who specializes in their condition, or face battles with 
insurance companies over treatments that are not covered because they are considered 
experimental or off-label for a rare cancer. This may result in greater financial burden and loss of 
time away from work if, for example, patients have to take off more time to travel for tests and to 
see specialists and have to pay more money out of pocket. Additionally, patients living with rare 
diseases/cancers experience work-place and health insurance discrimination (Williams, 2014).   
This unmet information need is an important consideration as it can be addressed.  For 
example, patients can be referred to social workers or free legal assistance centers that can 
address issues related to finances, insurances, and work. Public and consumer health libraries can 
also direct patients to information about financial, insurance, legal, and work-related resources as 
there are many online resources that address these information needs.  By recognizing this as an 
information need in this population, an emphasis on disseminating this information should be 
made a priority to ensure patients with rare cancers have easy access to financial, insurance, 
legal, and work-related information resources.    
Information Sources   
 Source preference and trust: While the majority of participants (80.9%) reported 
seeking information from the Internet, only 23% reported this as a source they preferred. 
Participants reported a preference for receiving information from their healthcare provider over 
all other sources; however, in contrast to their stated preference, reported using the Internet over 
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all other sources.  While sources used least were also reported as preferred least, patients may not 
be receiving sufficient information or they may perceive they are not receiving a sufficient 
amount of information from their preferred source, their healthcare provider.  This may be 
difficult to ascertain given some patients may believe there is more information to access than is 
available and some may desire to know everything about their rare cancer. 
Furthermore, participants reported they trust their healthcare providers more than any 
other source including the Internet.  The responses from this study demonstrate that patients are 
seeking information from the Internet, which is not their preferred source of information but is 
also not as trusted as health care providers a source for information about their rare cancers.   
This discrepancy in source preference and trust is concerning; however, it is not 
unexpected. Responses of the patients in this study are similar with regards to source preference 
and trust of sources in studies of patients diagnosed with general cancers. Those with general 
cancers report trusting their healthcare providers more than any other source, but also report 
predominantly using the Internet. Studies of general cancer patients show that patients trust their 
doctor or healthcare provider as the most trusted source of all sources including the Internet, 
family friends, radio, newspaper, or television (Shea-Budgell et al 2014; Halkett et al. 2012).  A 
secondary data analysis of HINTS survey data found that 38% of cancer patients reported 
seeking information from the Internet, more than any other source (Roach et al., 2009).   
A study that aimed to answer why patients use the Internet as a source of information 
over their healthcare providers found that the healthcare provider’s empathy and amount of time 
spent with the patient affect whether patients use the Internet substantially more as a source for 
finding health information (Tustin, 2010). Owing to the complexities of many rare diseases, 
including rare cancers, physicians may not have the time to adequately address all information 
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needs that patients with rare cancers may have. If patients perceive that their information needs 
have not been adequately addressed, patients then may seek the Internet to fill their unmet needs. 
Also, due to a lack of specialist physicians for many different rare cancers, particularly 
those that are very rare, there may be few physicians with knowledge of the specific rare cancer. 
(Spring, 2014b). Healthcare providers may have to search the literature to obtain an adequate 
level of information but for many rare cancers may also experience difficulty finding information 
about the condition due to the paucity of information. They may also not have the expert 
searching skills to find information that may be available and may also need to turn to other 
sources, such as physicians, government rare disease organizations, or a health sciences librarian. 
With very rare cancers, there simply may not be much at all known about them to find any 
substantive information in the consumer health or even the medical literature. 
Issues with patients searching the Internet. There are negative implications for patients 
not receiving information from their preferred source and then searching for information from 
the Internet. Studies show that patients make medical decisions based upon information they find 
on the Internet. Patients have been found to decline medical advice from qualified healthcare 
professionals, instead following the advice of information they found online. Patients report 
making decisions about their own or a loved one’s health based upon information they found 
online (Weaver, 2009; Fox, 2002). One study found that 11% of patients refused to follow the 
advice or discontinued their physician’s recommended treatment based upon information found 
online (Weaver, 2009). In another study, 68% of patients seeking online information reported the 
Internet had some impact on healthcare decisions and 16% reported the Internet had a major 
impact on healthcare decisions (Fox, 2002).   
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Reliable information provision for patients with rare cancers is crucial, particularly since 
some of these patients are utilizing Internet health websites and may potentially make decisions 
about their health based on this uncertain information. It is imperative that those with rare 
cancers be provided with access to health information portals containing high quality, accurate 
and credible sources of information. Patients who search the Web via online search engines may 
be unaware how to evaluate critically health information sources for accuracy and reliability and 
may thus be making decisions based on unreliable or inaccurate information. 
Information Satisfaction 
Though the majority of participants reported being satisfied with the information they 
received about their cancer, they reported frustration with finding and comprehending it. This 
may reflect the lack of consumer health information available online about many rare diseases 
including rare cancers.  There are few authoritative consumer-level rare disease/rare cancer 
websites available and are difficult to locate without sophisticated searching skills.  Patients may 
be overlooking these and other reliable sources of additional information about their cancers. For 
example, most participants in the study did not prefer or report using libraries, print resources, 
cancer organizations, videos, or interpersonal (communication with other patients) as sources of 
information.  Patients may benefit from using the help of trained health science librarians to 
access consumer level websites about rare conditions.  Most information available by doing a 
simple Google search of a rare disease are links to medical journal articles aimed at healthcare 
providers.  These articles are written at a very high reading level, containing complicated 
medical jargon, which makes it very difficult for the lay-person to understand. This may have 
reflected the high level of reported difficulty understanding information among patients in the 
study.  
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Furthermore, as discussed earlier, information from the Internet may contain inaccurate, 
biased, or even nefarious health information. The possible dangers of navigating the Internet can 
be ameliorated through the use of expert search services. For example, a consumer health cancer 
library that provides information about complicated medical issues, current therapies, and rare 
cancer types and subtypes reports benefits of their expert search service’s impact to its users 
(Volk, 2007). Volk (2007) found 96.2% of users of the service reported “some or all” 
information that they received through the expert searching service was not provided to them 
through any other informational sources (Volk, 2007) demonstrating the importance and benefit 
of expert searching for rare cancer information. 
In addition to overlooking libraries as a potential source of finding information, few 
reported using cancer organizations as a source for information. Cancer organizations can be an 
excellent source of finding additional information about specific rare cancers.  Many cancer 
organizations contain general cancer information but also contain information about specific 
cancers or can provide links to or contact information for disease-specific information and can 
also often provide disease specific brochures and pamphlets which are particularly helpful for 
those patients who do not prefer using the Internet.  These organizations not only provide disease 
information but also often provide users with support group information and places to connect 
with other patients who share similar medical issues providing a source for interpersonal 
information about rare cancers.  Patients with rare cancers can meet, communicate with, and 
learn from others who are experiencing similar medical issues.   
Like general cancers, patients with rare cancers do not report using videos as a source of 
information.  The low reported usage of video may be due to the lack of authoritative consumer-
oriented online cancer videos and difficulty obtaining DVD cancer videos. Even if located, 
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DVDs can often be cost prohibitive for patients. Videos are often an important resource for low-
literacy patients and having access to consumer level authoritative videos may be beneficial to 
those patients who have lower literacy or who prefer learning through audio-visual resources. 
 Despite participants reporting unmet needs, feeling that it took a lot of effort to find 
information, and feeling that the information was difficult to understand, the majority of the 
participants in this study of patients with rare cancers reported information satisfaction.  The 
number who reported being unsatisfied with information is roughly equal to other research of 
satisfaction with general cancer information. For example, Davies et al. (2008) report that 16% 
of patients diagnosed with breast or prostate cancer report that they were dissatisfied with the 
information they received about their cancers. A recent study showed that 34% of prostate cancer 
patients were dissatisfied with the information they received about their cancer, which was at a 
slightly greater level of dissatisfaction than what was found in this study of rare cancer patients 
(18.9%) (Lamers, Cuypers, Hunson, de Vries, & Kil, et. al, 2015). Even though these results are 
similar to patients diagnosed with general cancers, it was expected that the satisfaction with 
information would have been less in the rare cancer population than those diagnosed with more 
general types of cancers due to decreased information availability and difficulty finding 
information.  One hypothesis about this is that participants in this study may have reported 
satisfaction because they were satisfied with the care they received by their oncologist and 
healthcare team.  Due to the satisfaction of participants at the Massey Cancer Center, it may be 
beneficial to conduct a study of patients at other institutions to ascertain if patients with rare 
cancers are generally satisfied with information provision or whether information satisfaction 
may be an anomaly due to the fact that patients at the Massey Cancer Center are receiving 
adequate levels of health information from their healthcare providers.   
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Information satisfaction by demographics. Though men in this study reported higher 
information needs as discussed above, females actually reported a higher level of dissatisfaction 
with information provision than did males. This is also an important finding in this study as it 
shows that even though only 18.9% of the participants in this study are dissatisfied with the 
information they have received, the majority of those dissatisfied with information are females. 
Further research is needed to explore reasons why patients are dissatisfied with information, 
particularly females, so that information dissatisfaction can be addressed in the rare cancer 
patient population.   
Health-Related Quality of Life  
The research literature shows that unmet needs and low satisfaction with health information can 
be associated with negative health outcomes including reduced satisfaction with care, trust in 
physician, and health-related quality of life (Husson Mols, & Van de Poll-Franse, 2011).  A 
recent study of prostate cancer patients focusing on information provision and quality of life 
found that approximately 33% of the patients in the study were dissatisfied with health 
information provision and those patients had a significantly worse health-related quality of life 
than those who were satisfied with information received (Lamers et al, 2015). 
 Surprisingly, this study of patients with rare cancers conflicts with findings in the 
literature and showed no significant difference between health-related quality of life between 
those patients who reported information satisfaction and those reporting information 
dissatisfaction.  One possible reason may be due to the fact that only 18.9% of the participants in 
this study reported information dissatisfaction which is a low percentage of those who are 
dissatisfied. Lamers et. al (2015) study was a larger sample size including 999 patients with a 
response rate that produced a sample size of 697 participants. Of those participating, 222 (32%) 
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participants reported being dissatisfied with the information they received about prostate cancer. 
Perhaps information satisfaction and health-related quality of life should be examined in a 
subsequent study of information needs in a larger sample size of patients to identify if there is a 
correlation between information satisfaction and health-related quality of life among patients 
diagnosed with rare cancers. Another hypothesis of the reason for the discrepancy between this 
study and other studies regarding the relationship between information satisfaction and health-
related quality of life is that given the six-month time delay in obtaining eligible patients for this 
study, patients with lower health-related quality of life may have been deceased by the time they 
received the survey or may have been too ill to respond.  It is possible the responders were those 
who had a higher health-related quality of life compared to non-responders. 
Study Impact 
Traditionally, the rare disease/rare cancer community has been ignored and there is a general 
lack of knowledge about many individual rare cancers, resulting in many challenges for patients 
including the challenge of finding information about their condition. This long-standing neglect 
by the research community of the rare disease population has led to the growing trend of patient 
engagement in their own care and a sense of patient empowerment in the rare disease/rare cancer 
patient community (Ayme, Kole, & Groft, 2008).  The World Health Organization defines 
empowerment as, “a process through which people gain greater control over decisions and 
actions affecting their health (1998).”  On an individual level, through learning everything they 
can about their particular disease, patients with rare diseases become patient experts about their 
specific conditions (Ayme, Kole, & Groft, 2008; Spring, 2014a&b).  
 Patient empowerment also expands the concept of the engaged individual patient level to 
the greater rare disease community level.  The web has created the opportunity for establishing 
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rare disease/cancer online organizations and support groups where people with similar diseases 
can meet and discuss their shared experiences.  These organizations also present opportunities to 
build collaborative relationships with physicians to create online information portals that contain 
patient-level information that address the information needs of the rare cancer community.    
Overall, the identified information needs and unmet needs identified in this study show 
the importance of information provision, particularly disease-specific and treatment information 
to patients with rare cancers.  Information provision and access to reliable information is 
important for this population. In an effort to provide additional information patients can be 
encouraged to use other reliable sources to find additional information about their rare cancer if 
they are interested in more information.  
One easy and cost-effective way of promoting additional sources is via information 
prescriptions.  The National Institutes of Health and the National Library of Medicine sponsor 
the Information Rx project (www.informationrx.org). Information Rx provides free customizable 
prescription pads that can be used to direct patients to rare disease information portals, 
government agencies, directories for rare disease organizations and nearby libraries.  Healthcare 
providers are encouraged to write the name and stage of the cancer on the prescription so patients 
have the correct cancer name/spelling when searching for information. This also lessens the 
burden of the patient so that he/she does not have to remember the name of the cancer or how to 
spell it when searching online or when seeking information from other information sources. 
Because patients report using the Internet as a source of information over all other 
sources, patients should be directed by healthcare providers to websites that contain authoritative 
and accurate health information. Information prescriptions can also be used to provide the patient 
with pathfinders to reliable online resources.  As described above, a Google search may yield 
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results containing information that is written at a very high reading level, and may even contain 
bias or untrue information and patients may not critically evaluate informational sources before 
using them to make health care decisions.  While there is little information about rare cancers 
online, there are several portals of health information available that contain reliable information 
about many rare cancers. Patients should be directed to these portals. 
Given the findings of this study that patients with rare cancers report needing information 
about their diagnosis and treatment over all other information types, providing patients with this 
information is important.  Future efforts of rare disease organizations should focus on providing 
patients with basic information about rare cancers, with an emphasis on diagnosis information 
and treatment.  The National Institute of Health’s Genetic and Rare Disease Information Center 
(https://rarediseases.info.nih.gov/GARD/) provides a list of rare diseases including a section with 
links to many rare cancers.  The site provides very limited information about many rare cancers; 
however, this may be an excellent starting point for developing more consumer health 
information content about rare cancers with a focus on diagnosis and treatment information. 
Study Limitations 
Study limitations are outlined below with efforts used to ameliorate their effects on the study. 
Additionally, recommendations regarding how this study could be improved are included. 
 Nomenclature. A few participants reacted negatively to the word “rare” that was listed 
on the survey and in all letters informing the patients that the study explored the cancer 
information needs of patients diagnosed with rare cancers. These individuals were unaware that 
their cancer is considered rare or thought “rare” is an actual type of cancer. Using the word 
“uncommon” or the phrase “not commonly occurring” may have been a better choice of 
terminology and would not have elicited a negative response from patients. Most patients, 
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however, were keenly aware they had been diagnosed with a rare cancer and expressed their 
appreciation that this study focused on patients with rare cancers. 
Six-month embargo on cancer registry list. The Massey Cancer Center cancer registry 
was used to identify patients eligible for participation in the study.  The registry list, however, is 
on a six-month time delay meaning that patients are not listed in the registry until six months’ 
post diagnosis.  As a result of this delay in identifying eligible patients, several patients died 
prior to or after receiving the letter. Six patients were reported as having died by their spouse or 
other family member. It is also possible that many patients who did not respond to the survey 
were gravely ill or had recently died given the time from diagnosis to survey contact.   
 Generalizability of the study. This study may or may not be generalizable to other 
settings; however, since this study takes place at an academic safety net medical center, it may be 
representative of other similar safety net academic medical centers and generalizable to those 
centers.   
 Absence of level of education data. Originally, the researcher intended to collect data on 
cancer health literacy using the CHLT-6, however the CHLT-6 had not been validated for use in 
written surveys. The CHLT-6 was removed from the survey and the question regarding highest 
level of education was inadvertently left out in error.   Education level is acknowledged to be an 
important factor in health information needs and should be addressed in future studies of patients 
with rare cancers’ information needs. 
Method limitations.  This study used a cross-sectional design.  While there are many 
advantages to using a cross sectional design such as ease of study design, relatively low cost, and 
no concerns about the possibility of attrition, there are some disadvantages. One important 
limitation is that cross-sectional studies allow only an examination of one-time point.  Results 
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may have varied if the patient had received the survey at a different time-point in their healthcare 
journey.  Also, because we examined patients that were diagnosed within the past year, different 
patients were at varying stages in their healthcare journey.  For example, some patients may have 
finished treatment, whereas others were still undergoing treatment.  This is especially important 
regarding questions related to health-related quality of life. Patients who had finished treatment 
and were in remission may have felt better, thus, experiencing a higher health-related quality of 
life than patients who were still undergoing chemotherapy or some other treatment.  
Additionally, cross-sectional design studies do not allow for making causal inferences so 
this study only examined relationships between variables. As such this study did not attempt to 
make any type of causal inference between any of the variables included in this study.  
Survey instruments. This study utilized the SF-12v.1 to measure patients’ health-related 
quality of life.  At the time of study conception there were many versions of this instrument 
available online. Some contained different response options for the question about physical or 
emotional health interfering with social activities. This researcher obtained the survey initially 
through the organization that developed the measure for the Patient Reported Outcomes study. 
Subsequently, the rights to the SF12 were obtained by Optum and this researcher obtained 
approval from Optum to use the measure. Optum, does not recognize a previous response option 
“A good bit of the time” and no longer allows for scoring of this response option with their 
scoring software.  Additionally, in order to ensure validity of the measure, Optum does not allow 
for any formatting changes of the measure.  Because this measure was included in a survey 
booklet with other measures (following the Dillman Tailored Design Method), formatting of the 
SF-12 was changed to align with the formatting of the survey booklet to ensure patient ease in 
following instructions and completing questions.  A brief description of the measure was added 
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before the survey questions, questions were renumbered to align with sequencing of all questions 
in the survey booklet and minor changes were added to wording to allow for patients to follow 
instructions of the questionnaire easily. Optum made an exception to their formatting rules since 
the content remained the same and licensed it to Virginia Commonwealth University for this 
study. (License # QN035780). 
Additionally, minor changes were made to the EORTC questionnaire. The EORTC 
instrument is a reliable and validated instrument that measures information received.  In addition 
to measuring information received, questions about different types of information found in the 
EORTC information received measure were also reworded to measure information needs.  This 
allowed us to 1.) measure information needs since there were no other measures that adequately 
measured various types of information needs that we desired to measure in this study, and 2.) 
allowed for a direct comparison of information needs and received information.  Because the 
modified EORTC questions used to measure information needs in this study have not been 
validated to measure needs, a limitation exists in using this to measure information needs. 
Mailed survey limitations. There are benefits and limitations to using written mailed 
surveys.  First, mailed survey are only received by patients with a permanent mailing address, 
resulting in possible selection bias. Additionally, there is no way of ensuring that only the actual 
patient completes the survey.  The participant’s spouse, parent, or adult child may have 
completed and returned the survey for the patient without our knowledge.  Also, without 
assistance and guidance which is possible with in-person or telephone surveys, patients may skip 
questions, check multiple boxes, not follow the survey directions, or accidentally skip large 
sections of the survey. Missing data is a limitation of mailed surveys since participants may 
either accidentally skip sections or may decide not to answer certain questions. 
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Measurement error is another consideration in mailed surveys (Dillman, 1991).  
Participants may intentionally or unintentionally be unable to provide accurate information in 
response to the survey. Also, unlike having the questions read to them in a telephone or in-person 
survey, mailed surveys require a high level of literacy to read and complete. Low literacy may 
result in measurement error if the patient is unable to understand the questions. 
Even though there were limitations of the mailed survey there are also many advantages 
to using a mailed survey method. The promised 80% response rate of the tailored design method 
of mailed surveys is a benefit to using mailed surveys. This study achieved only a 53.2% 
response rate; however, this population was comprised of patients who have been diagnosed with 
rare cancers that have high associated morbidity and mortality rates.  Lack of response may be 
due the result of some participants being too ill to participate. Because there was a six-month 
delay receiving the patient list from the cancer registry, patients were six to twelve months’ post-
diagnosis and their health status could have been adversely compromised by the time the surveys 
were mailed.  As noted, six (3.0%) patients’ family members called to inform us that the patient 
had recently passed away.  
Importantly, mailed surveys are also much faster for participants to complete and are less 
burdensome than other methods such as telephone surveys, an advantage when working with 
patients who may be ill.  Participants can begin and complete the surveys on their own time and 
pace.  Although a potential limitation for the study, an advantage of mailed surveys to 
participants is that those who do not wish to participate do not have the additional burden of 
declining participation directly and can simply not return the survey.   
Receiving mail. Patients were asked to return the mailed surveys in a self-addressed 
stamped envelope containing the researcher’s mailing address at the university.  Because the 
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mail schedule was unpredictable, receiving in batches every six to eight weeks following the 
tailored design method frequency of mailing letters was difficult.  The mailing schedule for the 
fourth letter containing an identical survey, in case the original was lost, was supposed to be sent 
two weeks following the third letter. Participants who had previously completed and returned the 
survey were also sent a second survey due to the mail delay.  A small number of participants 
(n=3) completed the second identical survey and returned it, thus resulting in multiple surveys 
received from the same participants. For duplicates, one survey from each participant was 
randomly selected for inclusion in the study. To correct for potential duplications and to lessen 
the burden on participants so they did not feel obligated to complete two identical surveys, the 
researcher delayed sending the fourth letter until after approximately 50% of that groups’ 
surveys had been returned.  The mail delivery issues noted above may have affected the overall 
response rate. Had mail delivery been timely, the study may have achieved a higher response rate 
as demonstrated by other studies using the Dillman method. In future studies, a dedicated postal 
box should be used to ensure mail is received in a timely manner. 
Study Strengths 
Overall, it is recognized the limitations outlined above exist, however, they are outweighed by 
the many strengths and benefits of this study.  
Fills a needed gap in the literature. Most importantly, this is the first study to examine 
the information needs and sources of the rare cancer patient population. The results from this 
study contribute to the rare cancer information needs and sources literature, filling an important 
gap in the literature. 
Ameliorates gap in knowledge. The information from this study about information 
needs and sources in this traditionally overlooked population is beneficial so that patients’ 
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information needs can be addressed and needs can be met. The results from this study provide 
healthcare providers with important information regarding needs which are most important to 
patients with rare cancers and identifies the areas where there are unmet needs. With these unmet 
needs identified, pertinent resources can be made available to patients. 
Study location. This study was conducted at a large academic medical center, which is a 
safety net hospital serving a diverse population. This provided the opportunity for a diverse 
population of patients to participate in the study. 
Validated measures. Another strength of the study is that validated measures were used 
to assess information needs/received, information sources, and health-related quality of life.   
Rare cancer list. There are few lists available of cancers that are considered rare to use 
as a guide to identify which cancers are considered rare.  This study uses cancers listed in the 
Textbook of Uncommon Cancers and selected cancers from the Office of Rare Disease Research 
(ORDR) rare cancer list. The researcher consulted with a medical oncologist and the editor of the 
Textbook of Uncommon Cancers to create the list. The resulting list is a very thorough 
delineation of cancers that are considered rare in the United States. 
Future Studies 
 This study filled a much needed gap in the study of information needs and sources of patients 
with rare cancers, however, there is much more to learn regarding the informational needs and 
sources of this population.  While the cancers used to identify eligible rare cancers in this study 
were all considered rare, a next step may be to examine the differences between the needs of 
those in this study who had the rarest cancers seen at the study site compared to those whose rare 
cancers are more commonly seen there. Based upon the results, it may also be beneficial to 
conduct a similar study with exclusively rarer cancers that are not commonly seen at the Massey 
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Cancer Center.  Due to information satisfaction at the Massey Cancer Center, another next study 
may need to be conducted at other sites to assess information needs of this population and 
ascertain health information satisfaction in the rare cancer population. 
Additionally, a comparison of information needs of patients with rare cancers with those 
diagnosed with general/common cancers would also be important to ascertain the differences in 
information needs, sources, and information satisfaction between those diagnosed with general 
cancers and those diagnosed with rare cancers.  
This study also did not examine where patients were on the cancer care continuum since 
these patients were at different stages along the healthcare continuum.  It would be beneficial to 
conduct a longitudinal study of the information needs and sources of patients with rare cancers 
throughout the cancer care continuum to ascertain the needs of patients throughout their cancer 
care journey.  
A future project based upon the results of the information needs of patients would be the 
development of a government-sponsored rare cancer information portal. As discussed earlier, a 
rare cancer information portal aimed specifically at meeting the information needs of patients 
with rare cancers would be especially beneficial for providing reliable and accurate information 
to patients and fill a much needed information gap.  This resource would benefit patients who 
want to learn more about their cancers. Additionally, it would contribute to the building of 
information services for the rare cancer community and would enable and empower patients by 
providing them information to become patient experts about their rare condition. 
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VII. Conclusion 
 
This cross-sectional study examined the information needs and sources used by patients 
who have been diagnosed with rare cancers.  As detailed above, patients with rare cancers 
experience many challenges during their health care journey, including difficulty finding 
authoritative information to satisfy their information needs. 
 As described above, the rare cancer population has traditionally been ignored by the 
research community and very little has been written describing the unique information needs and 
sources of patients with rare cancers.  Most of the literature regarding information needs focuses 
on patients with general cancers (non-rare) or on the parents of children with rare genetic 
diseases.  Additionally, most of the existing studies published on the information needs of rare 
diseases are small qualitative studies of patients in European countries.   
Overall, this study fills a critical gap in the rare cancer literature by identifying patients’ 
information needs and sources. This study demonstrates that there are many unmet needs, 
particularly in the provision of disease-specific information, treatment, and treatment options. 
The patients in this study reported they are not receiving information from their preferred source, 
healthcare providers, and are turning to the Internet for information even though they do not 
report high levels of trust for this source.  Even though the majority of patients in the study were 
satisfied overall with the information they received, nearly 20% were not satisfied.  Almost all 
patients reported desiring more information. Additionally, many reported that it took effort to 
find, were frustrated with their searches, found that the information was difficult to understand, 
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and were concerned about the quality. Even though there are government organizations created 
to address the informational needs of patients with rare cancers, these results show that much 
more needs to be for this traditionally underserved population. 
 Perhaps, with a better understanding of rare cancer patients’ information needs and 
sources of information, improvements can be made in the provision of authoritative information 
at the health care level and development of improved online information portals.  Improved 
information provision may, in turn, improve rare cancer patients’ efforts to become empowered 
patients and enable them to become patient experts about their particular rare cancers.  Effective 
information provision can lead to increased met needs and satisfaction which may also have a 
positive effect on patient outcomes such as improved health-related quality of life.   
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Thank you for taking the time to complete this 
survey about your health information needs.  We 
appreciate your help. 
 
Your responses are voluntary and will be kept confidential.  By completing and 
returning the survey you are consenting to participate in this research study. 
 
 
 
 
 
 
 
  If you have any questions about this study, please contact Dana Ladd by telephone at 804-628-2429 or by email at dlladd@vcu.edu.  
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Health Information Needs 
These are some questions about the different types of information you may have needed about 
your cancer or treatment.  For each type of information, check the box to show how much 
information you needed. 
Q1. During your current disease or treatment, did you need information on… 
 Not at 
all 
A Little Quite a 
Bit 
Very 
Much 
1. The diagnosis of your cancer?         
2. The extent (spread) of your cancer?         
3. The possible causes of your cancer?         
4. Whether the cancer is under control?         
5.Whether family members are also at risk of 
developing cancer? 
        
6. The purpose of any medical tests you have had 
or may undergo? 
        
7. The procedures of the medical tests?         
8. The results of the medical tests you have 
already received? 
        
9. The medical treatment (chemotherapy, 
radiotherapy, surgery or other modality)? 
        
10. The expected benefit of the treatment?         
11. The possible side-effects of the treatment?         
12. The expected effects of the treatment on 
cancer symptoms? 
        
13. The effects of the treatment on social and 
family life? 
        
14. The effects of the treatment on sexual 
activity? 
        
15. The effects of treatment on fertility (the 
ability to have a baby)? 
        
16. Other treatment options?         
17. Financial, insurance, work-related or legal 
resources? 
        
18. Additional help outside the hospital (e.g. help 
with daily activities, self-help groups)? 
        
19. Rehabilitation services (e.g. physiotherapy, 
occupational therapy)? 
        
20. Aspects of managing your illness at home?         
21. Possible professional psychological support?         
22. Different places of care (hospitals/outpatient 
services/home)? 
        
23. Things that you can do to help yourself get 
well (rest, contact with others…) 
        
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Health Information Received 
These are some questions about the different types of information you may have received about 
your cancer or treatment.  For each type of information, check the box to show how much 
information you have received. 
Q2. During your current disease or treatment, how much information have you received 
on…  
Not at all A Little Quite a Bit Very 
Much 
1. The diagnosis of your cancer?         
2. The extent (spread) of your cancer?         
3. The possible causes of your cancer?         
4. Whether the disease is under 
control? 
        
5. Whether family members are also at 
risk of developing cancer? 
        
6. The purpose of any medical tests you 
have had or may undergo? 
        
7. The procedures of the medical tests?         
8. The results of the medical tests you 
have already received? 
        
9. The medical treatment 
(chemotherapy, radiotherapy, surgery 
or other modality)? 
        
10. The expected benefit of the 
treatment? 
        
11. The possible side-effects of the 
treatment? 
        
12. The expected effects of the 
treatment on cancer symptoms? 
        
13. The effects of the treatment on 
social and family life? 
        
14. The effects of the treatment on 
sexual activity? 
        
15. The effects of treatment on fertility 
(the ability to have a baby)? 
        
16. Other treatment options?         
17. Financial, insurance, work-related 
or legal resources? 
        
18. Additional help outside the hospital 
(e.g. help with daily activities, self-help 
groups)? 
        
19. Rehabilitation services (e.g. 
physiotherapy, occupational therapy)? 
        
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Q2. (continued) During your current disease 
or treatment, how much information have 
you received on… 
 
Not at all A Little Quite a Bit Very 
Much 
20. Aspects of managing your illness at 
home? 
        
21. Possible professional psychological 
support? 
        
22. Different places of care 
(hospitals/outpatient services/home)? 
        
23. Things that you can do to help 
yourself get well (rest, contact with 
others…) 
        
24. Have you received written 
information? 
 Yes  No  
25. Have you received information on 
CD or tape/video? 
 Yes  No  
26. Overall, were you satisfied with the 
information you received?  
 Yes  No  
27. Do you wish to receive more 
information? 
 Yes  No If yes go to question 
27a 
If no go to question 28 
27a. If yes, please specify on which 
topics? 
  
28. Do you wish you had received less 
information? 
 Yes  No If yes go to question 
28a 
If no go to question 29 
28a. If yes, please specify on which 
topics? 
 
 
 
Not at all A Little Quite a Bit Very 
Much 
29. Overall has the information you 
have received been helpful? 
        
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Where you Look for Health Information 
These questions are about where you look for health information about cancer.  For each, 
check the box for your answers about where you look for information. 
 
Q3. Have you ever looked for information about health or medical topics from any 
source? 
 Yes [If yes, go to question 3A] 
 No [If no, go to question, go to question 4] 
Q3A. The most recent time you looked for information about health or medical 
topics, where did you go first? Choose one 
 
a. Books 
b. Brochures, pamphlets, etc. 
c. Cancer organization 
d. Family 
e. Friend/Co-Worker 
f. Doctor or health care provider 
g. Internet 
h. Library 
i. Magazines 
j. Newspapers 
k. Telephone information number 
l. Complementary, alternative, or unconventional practitioner 
m. Other-Specify-  
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Q3B. When you look for information about health or medical topics, where did you 
go?  Choose all that apply 
 
a. Books 
b. Brochures, pamphlets, etc. 
c. Cancer organization 
d. Family 
e. Friend/Co-Worker 
f. Doctor or health care provider 
g. Internet 
h. Library 
i. Magazines 
j. Newspapers 
k. Telephone information number 
l. Complementary, alternative, or unconventional practitioner 
m. Other-Specify-  
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Q4. From where do you prefer to receive information about your cancer? Choose one 
a. Books 
b. Brochures, pamphlets, etc. 
c. Cancer organization 
d. Family 
e. Friend/Co-Worker 
f. Doctor or health care provider 
g. Internet 
h. Library 
i. Magazines 
j. Newspapers 
k. Telephone information number 
l. Complementary, alternative, or unconventional practitioner 
m. Other-Specify- 
 
Q5. Based on the results of your most recent search for information about health or 
medical topics, how much do you agree or disagree with each of the following 
statements? 
 Strongly 
Agree 
Somewhat 
Agree 
Somewhat 
Disagree 
Strongly 
Disagree 
a. It took a lot of effort to get the 
information you needed. 
        
b. You felt frustrated during your 
search for the information 
        
c.  You were concerned about 
the quality of the information 
        
d. The information found was 
hard to understand 
        
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Q6. Overall, how confident are you that you could get advice or information about 
health or medical topics if you needed it? 
 
1. Completely confident 
2. Very Confident 
3. Somewhat confident 
4. A little confident 
5. Not confident at all 
Q7. In general, how much would you trust information about health or medical topics 
from each of the following? 
 
 Not at all A Little Some A Lot 
a. A doctor         
b. Family or friends         
c.  Newspapers or magazines         
d. Radio         
e. Internet         
f. Television         
g. Government health 
agencies 
        
h. Charitable organizations         
i. Religious organizations and 
leaders 
        
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Your Health-Related Quality of Life 
These questions ask for your views about your health.  These questions are about how you feel 
and how well you are able to do your usual activities. Check the box for each question that 
describes how you feel. 
Q8.  In general, would you say your health is: 
  Excellent 
 Very Good 
  Good  
  Fair  
 Poor  
Q9. The following two questions are about activities you might do during a typical day.  
Does your health limit you in moderate activities, such as moving a table, pushing a vacuum 
cleaner, bowling, or playing golf? 
 Yes, Limited A Lot  
 Yes, Limited A Little  
 No, Not Limited At All  
Does your health limit you in climbing several flights of stairs? 
 Yes, Limited A Lot  
 Yes, Limited A Little  
  No, Not Limited At All  
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Q10. During the past 4 weeks have you had any of the following problems with your work 
or other regular activities as a result of your physical health and . . . 
Accomplished less than you would like: 
 Yes  
 No  
 
Were limited in the kind of work or other activities: 
 Yes  
  No  
 
Q11. During the past 4 weeks, were you limited in the kind of work you do or other regular 
activities as a result of any emotional problems (such as feeling depressed or anxious) and… 
Accomplished less than you would like: 
 Yes 
 No  
 
Didn’t do work or other activities as carefully as usual: 
 Yes  
 No  
Q12. During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework)? 
 Not At All  
 A Little Bit  
 Moderately  
 Quite A Bit  
 Extremely  
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Q13. The next three questions are about how you feel and how things have been during the 
past four weeks. For each question, please give the one answer that comes closest to the way 
you have been feeling. How much of the time during the past 4 weeks – 
Have you felt calm and peaceful? 
 All of the Time  
 Most of the Time  
 A Good Bit of the Time  
 Some of the Time  
 A Little of the Time  
 None of the Time  
 Did you have a lot of energy? 
 All of the Time  
 Most of the Time  
 A Good Bit of the Time  
 Some of the Time  
 A Little of the Time  
 None of the Time  
 
Have you felt downhearted and blue? 
 All of the Time  
 Most of the Time  
 A Good Bit of the Time  
 Some of the Time  
 A Little of the Time  
 None of the Time  
Q14. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting with friends, relatives, etc.)? 
 All of the Time  
 Most of the Time  
 A Good Bit of the Time  
 Some of the Time  
 A Little of the Time  
 None of the Time  
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Questions About You 
 
Q15. What is your gender? 
 Male 
 Female 
 
Q16. What is your age?  
  
Q17. Are you Hispanic or Latino? 
 Hispanic 
 Not Hispanic 
Q18. What is your race? 
 Black or African American 
 White or Caucasian 
 Asian 
 Native American or Alaska native 
 Native Hawaiian or Other Pacific Islander 
 Multi-racial  
 Other  
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Q19. What kind of medical insurance coverage do you have? 
 
 None 
 Private insurance 
 Employer sponsored insurance 
 Self-pay 
 Medicare 
 State-sponsored Indigent Care Program 
 Virginia Coordinated Care Program 
 Medicaid 
 Military 
 Not sure 
 Other _________________________ 
 
Q20. Which of the following best describes your employment status? 
 Full-time paid 
 Part-time paid 
 Retired 
 Unemployed 
 Homemaker 
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Q21. Which category represents your combined total household income during the last 12 
months? This includes money from jobs, net income from business, or farm or rent, 
pensions, dividends, interest, social security payments, disability and any other money 
income received by everyone in your household. 
 Less than $5,000 
 $5,001 - $10,000 
 $10,001 – $15,000 
 $15,001 - $20,000 
 $20,001 - $25,000 
 $25,001 - $30,000 
 $30,001- $40,000 
 $40,001 - $50,000 
 $50,001 - $60,000 
 $60,001 - $70,000 
 $70,001 - $80,000 
 $80,001 - $90,000 
 $90,001 - $100,000 
 Greater than $100,000 
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Thank You! 
 
 
 
 
 
 
 
 
 
 
Please return your survey in the enclosed envelope 
or use the following address: 
Dana Ladd 
c/o Robin Matsuyama Ph.D 
Box 980149 
Department of Social and Behavioral Health 
Virginia Commonwealth University 
Richmond, VA 23298-0149
Comments: 
  
 
Appendix B 
 
Letters 
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Research Participant Introductory Letter 
 
<Date> 
<Address Line 1> 
<Address Line 2> 
Address Line 3> 
 
Dear <patient name>:  
 
I am writing to ask for your help with an important research study I am conducting at the 
Virginia Commonwealth University Massey Cancer Center. The purpose of this research study is 
to find out more about the health information needs and health information sources of patients 
who have been diagnosed with cancers that are considered rare. In the next few days you will 
receive a request to participate in this project by answering a survey about your health 
information needs and the sources of information you use to find health information about 
cancer. I hope this study will contribute to improving patients’ access to reliable information 
about rare cancers. 
 
We would like to do everything we can to make it easy and enjoyable for you to participate in 
the study.  I am writing in advance because many people like to know ahead of time that they 
will be asked to fill out a questionnaire.  This research can only be successful with the generous 
help of people like you.  
 
To say thanks, you will receive a small token of appreciation with the request to participate.  I 
hope you will take 10-15 minutes of your time to help us. 
 
Sincerely, 
         
Dana L. Ladd, MS SLIS  
Department of Social and Behavioral Health 
Virginia Commonwealth University 
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Research Participant Initial Invitation Letter 
 
<Date> 
<Address Line 1> 
<Address Line 2> 
<Address Line 3> 
 
Dear <patient name>: 
 
I am inviting you to participate in a research study I am conducting at the Virginia 
Commonwealth University Massey Cancer Center. You are being contacted because you have 
been diagnosed with a cancer that is considered rare and your physician agreed this was a study 
for which you are potentially eligible.  Your participation will not interfere with any care or 
treatment you may be receiving at this time.  The purpose of this research study is to find out 
more about the health information needs and health information sources of patients who have 
been diagnosed with rare cancers.   
 
You are being asked to complete a written survey about your health information needs. The 
questions take about 15 minutes to complete.  Your responses are voluntary and will be kept 
confidential.  By completing and returning the survey you are consenting to participate in this 
research study.  If you have any questions about this study, please call Dana Ladd at 804-628-
2429 or email at dlladd@vcu.edu.  Data are being collected only for research purposes.  All 
personal identifying information will be kept in password-protected files on a secure server.  
Your data will be identified by ID numbers, not names, and stored separately from research data 
in locked files in the researcher’s office.  Although the study team has put in safeguard to protect 
your information, there is always a potential risk of loss of confidentiality.  We will not tell 
anyone the answers you give us and we will not use your name when we are reporting on the 
study.  This study has been reviewed and approved by the Virginia Commonwealth University 
Institutional Review Board, and if you have any questions about your rights as a participant in 
this study, you may contact them by telephone at 804-827-2157. 
 
You may not receive any direct benefit from this study, but by taking a few minutes to share 
your thoughts about your health information needs, you will help us in improving access to 
reliable health information about rare cancers. If you wish to participate in this study, please 
complete the enclosed survey and mail back to us in the enclosed addressed stamped envelope.  
A small token of appreciation is enclosed as a way of saying thank you. 
 
Your alternative is to not participate in the study. Your care at Massey Cancer Center will not be 
affected by whether or not you participate in the study. If you do not wish to participate in the 
study, you may opt out of receiving any future letters by emailing dlladd@vcu.edu or calling 
Dana Ladd at 628-2429. 
 
I truly appreciate your time and help with the study. 
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Sincerely,         
Dana L. Ladd, MS SLIS 
Department of Social and Behavioral Health 
Virginia Commonwealth University 
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Research Participant Reminder Letter 
 
<Date> 
<Address Line 1> 
<Address Line 2> 
Address Line 3> 
 
Dear <patient name>: 
 
Last week a questionnaire was mailed to you asking you to participate in a study about the health 
information needs of patients diagnosed with cancers that are considered rare. 
 
If you have already completed and returned the questionnaire, please accept our sincere thanks.  
If not, please consider completing and returning the survey as soon as possible.  We are 
especially grateful for your help with this important study.  If you did not receive the 
questionnaire, if you have any questions about this study, or if you do not want to receive any 
future letters about this study, please call Dana Ladd at 804-628-2429 or email at 
dlladd@vcu.edu.   
 
 
 
Sincerely, 
         
Dana L. Ladd, MS SLIS 
Department of Social and Behavioral Health 
Virginia Commonwealth University 
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Research Participant Information (Follow-up) Letter 
 
<Date> 
<Address Line 1> 
<Address Line 2> 
Address Line 3> 
 
Dear <patient name>: 
 
In <insert date> we sent you a letter requesting that you complete a questionnaire about your 
cancer health information needs.  To the best of our knowledge, it has not yet been returned.  
 
We are writing again because of the importance that your feedback can provide to our study 
about patients’ health information needs.  We hope that you will fill out and return the enclosed 
questionnaire as soon as possible.   
 
As mentioned before the questions take about 15 minutes to complete.  Your responses are 
voluntary and will be kept confidential. If you have any questions about this study, please call 
Dana Ladd at 804-628-2429 or email at dlladd@vcu.edu.  This study has been reviewed and 
approved by the Virginia Commonwealth University Institutional Review Board, and if you have 
any questions about your rights as a participant in this study, you may contact them by telephone 
at 804-827-2157. By completing and returning this survey, you are consenting to participate in 
this research study.   
  
Thank you for your time and help with this research study. 
 
 
Sincerely, 
         
Dana L. Ladd, MS, SLIS 
Department of Social and Behavioral Health 
Virginia Commonwealth University 
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Research Participant Information Final Letter 
 
<Date> 
<Address Line 1> 
<Address Line 2> 
Address Line 3> 
 
Dear <patient name>: 
 
I am writing one last time to thank you for participating in the Health Information Needs study.  
The responses we have received have been invaluable.  If you have not yet had a chance to send 
us your responses, you are welcome to do so and we would still appreciate your help completing 
the survey.  We will continue to accept questionnaires until <date> at which point we will move 
to the next stage of the study. 
 
If you have any remaining questions about this survey of cancer health information needs, I will 
be happy to help and can be reached by telephone at 804-628-2429 or by email at 
dlladd@vcu.edu.   
 
I truly appreciate your time and help with the study. 
 
Sincerely, 
         
Dana L. Ladd, MS, SLIS 
Department of Social and Behavioral Health 
Virginia Commonwealth University 
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Appendix C  
 
Cancer Types, Sites, and Stage by Demographics 
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Table 14: Cancer histology group and behavior descriptions of study participants by 
demographics 
Histology Group Description 
Histology Behavior Description 
Primary Cancer Site Derived 
Stage 
(AJCC 
V7) 
Derived 
Stage 
Grouped 
Gender 
M=Male 
F=Female 
 
Age Race 
W=White 
NW=Non-
White 
Acinar Cell Carcinoma       
Acinar cell carcinoma Parotid gland III III F 63 NW 
Adenocarcinoma with Metaplasia       
Metaplastic Carcinoma 
Metaplastic Carcinoma 
Breast 
Breast 
IIIB 
IIIA 
III 
III 
F 
F 
63 
49 
W 
NW 
Adenocarcinoma, NOS       
Adenocarcinoma, NOS 
Adenocarcinoma, NOS 
Adenocarcinoma, NOS 
Endocervix 
Ileum 
Duodenum 
IIIB 
IV 
IV 
III 
IV 
IV 
F 
F 
M 
33 
67 
73 
W 
W 
W 
Adenoid Cystic & Cribriform CA.       
Adenoid Cystic Carcinoma 
Adenoid Cystic Carcinoma 
Cheek mucosa 
Overlapping lesion 
breast 
I 
IIA 
I 
II 
F 
F 
65 
72 
W 
NW 
Astrocytoma, NOS       
Astrocytoma, anaplastic 
Astrocytoma, anaplastic 
Frontal lobe 
Parietal lobe 
NA 
NA 
NA 
NA 
M 
F 
58 
35 
W 
NW 
Carcinoid Tumor, Malignant       
Carcinoid Tumor, Malignant 
Carcinoid Tumor, Malignant 
Carcinoid Tumor, Malignant 
Carcinoid Tumor, Malignant 
Carcinoid Tumor, Malignant 
Carcinoid Tumor, Malignant 
Carcinoid Tumor, Malignant 
Neuroendocrine carcinoma 
Neuroendocrine carcinoma 
Merkel cell carcinoma 
Merkel cell carcinoma 
Goblet Cell Carcinoma 
Rectum, NOS 
Rectum, NOS 
Ileum 
Ovary 
Ileum 
Ileum 
Small Intestine 
Gallbladder 
Ovary 
Skin-upper limb 
Skin-scalp/neck 
Appendix 
I 
UNK 
IIIB 
IA 
IIIA 
IIA 
IIIB 
NA 
IV 
IIB 
UNK 
IIA 
I 
UNK 
III 
I 
III 
II 
III 
NA 
IV 
II 
UNK 
II 
M 
F 
M 
F 
F 
F 
F 
F 
F 
F 
M 
F 
76 
62 
62 
66 
68 
69 
61 
55 
26 
74 
68 
59 
NW 
NW 
W 
W 
NW 
W 
W 
NW 
W 
NW 
W 
W 
Carcinoma, NOS       
Carcinoma, NOS Parotid Gland IVC IV M 60 W 
Carcinoma, Undiff., NOS       
Pleomorphic carcinoma Parotid Gland IVC IV M 72 W 
Carcinosarcoma, NOS       
Carcinosarcoma, NOS Endometrium IIIA III F 78 NW 
Cholangiocarcinoma       
Cholangiocarcinoma 
Cholangiocarcinoma 
Biliary Tract, NOS 
Intrahepatic bile duct 
NA 
II 
NA 
II 
M 
M 
42 
73 
W 
W 
Chronic Myeloproflierative Dis.       
Myelosclerosis w/myeloid 
metaplasia 
Essential thrombocythemia 
Essential thrombocythemia 
Bone Marrow 
 
Bone Marrow 
Bone Marrow 
NA 
 
NA 
NA 
NA 
 
NA 
NA 
F 
 
F 
M 
56 
 
41 
68 
W 
 
W 
NW 
Clear Cell Adenocrcinoma, NOS       
Clear Cell Adenocarcinoma, NOS 
Clear cell adenocarcinoma, NOS 
Renal Cell Carcinoma, 
Chromophobe type 
Cervix uteri 
Upper lobe, lung 
Kidney 
IB1 
IB 
I 
I 
I 
I 
F 
M 
F 
39 
71 
68 
W 
W 
W 
Cystadenocarcinoma, NOS       
Serous cystadenocarcinoma,NOS Fallopian Tube IA I F 55 W 
Endometrioid Adenocarcinoma       
Endometrioid carcinoma 
Endometrioid carcinoma 
Cervix Uteri 
Ovary 
IVB 
IIIA 
IV 
III 
F 
F 
67 
74 
NW 
W 
Erythroid Leukemia       
Acute myeloid leukemia, M6 Bone Marrow NA NA F 53 W 
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Ewing Sarcoma       
Ewing Sarcoma 
 
Ewing Sarcoma 
Long Bones/upper 
limb 
Pelvic Bones 
IIA 
 
IVA 
II 
 
IV 
M 
 
M 
31 
 
20 
NW 
 
W 
Fibromatous Neoplasms       
Fibrosarcoma 
 
Solitary Fibrous tumor, malignant 
 
Fibromyxosarcoma 
 
Fibromyxosarcoma 
Fibromyxosarcoma 
Fibromyxosarcoma 
Connective, 
subcutaneous 
Connective, 
subcutaneous 
Connective, 
subcutaneous 
III 
 
IIB 
 
III 
 
IIA 
IIB 
III 
III 
 
IIB 
 
III 
 
II 
II 
III 
M 
 
F 
 
M 
 
F 
M 
M 
77 
 
40 
 
77 
 
69 
79 
53 
W 
 
W 
 
W 
 
W 
W 
NW 
Fibrous Histiocytoma, Mal.       
Dermatofibrosarcoma, NOS 
Dermatofibrosarcoma, NOS 
Skin of trunk 
Vulva, NOS 
NA 
NA 
NA 
NA 
F 
F 
35 
63 
NW 
NW 
Follic. & Marginal Lymh, NOS       
Follicular lymphoma, NOS 
Marginal zone B-cell lymphoma 
Small intestine, NOS 
Ethmoid sinus 
IIEA 
IIEA 
II 
II 
M 
M 
65 
73 
W 
W 
Glioblastoma, NOS       
Gliosarcoma 
Glioblastoma, NOS 
Glioblastoma, NOS 
Glioblastoma, NOS 
Glioblastoma, NOS 
Temporal Lobe 
Frontal Lobe 
Parietal Lobe 
Parietal Lobe 
Temporal Lobe 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
M 
M 
M 
M 
M 
62 
83 
47 
78 
53 
W 
W 
W 
NW 
W 
Hemangioendothelioma       
Epitheloid 
Hemangioendothelioma 
Liver NA NA F 60 W 
Immunoproliferative Diseases       
Waldenstrom macroglobulinemia Blood NA NA M 72 W 
Kaposi Sarcoma       
Kaposi Sarcoma Skin, NOS NA NA M 41 NW 
Liposarcoma Neoplasms       
Myxoid Liposarcoma Connective, 
subcutaneous 
IB I F 67 W 
Lymphoepithelial Carcinoma       
Basaloid squamous cell 
carcinoma 
Basaloid squamous cell 
carcinoma 
Base of tongue, NOS 
 
Larynx, NOS 
IVA 
 
IVA 
IV 
 
IV 
M 
 
M 
50 
 
58 
W 
 
W 
Malignant Lymphoma, NOS       
Primary Cutaneous Follicle 
Centre Lymphoma 
Skin of scalp and 
neck 
IE I F 74 NW 
ML, Large B-Cell, Diffuse       
Burkitt Lymphoma, NOS 
ML, Large B-cell, diffuse 
 
ML, Large B-cell, diffuse 
ML, Large B-cell diffuse 
 
Breast NOS 
Connective, 
subcutaneous 
Connective 
Short bones/lower 
limb 
IEA 
IEA 
 
IIEA 
IEA 
I 
I 
 
II 
I 
F 
F 
 
M 
M 
36 
35 
 
93 
60 
NW 
W 
 
NW 
W 
ML, Small B-Cell Lymphocytic       
Mantle cell lymphoma 
 
Mantle cell lymphoma 
Lymph 
nodes/multiple 
regions 
Palate, NOS 
IVB 
 
IEA 
IV 
 
I 
M 
 
F 
70 
 
46 
W 
 
W 
Mucinous Adenocarcinoma       
Mucinous Adenocarcinoma Lower lobe, lung IB I M 63 W 
Mucoepidermoid Carcinoma       
Mucoepidermoid Carcinoma Parotid Gland I I F 50 W 
Myeloid Leukemia, NOS       
Chronic Myeloid Leukemia Bone Marrow NA NA M 71 W 
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Chronic Myeloid Leukemia Bone Marrow NA NA M 44 W 
Myomatous Neoplasms       
Leiomyosarcoma, NOS 
 
Leiomyosarcoma, NOS 
 
 
Leiomyosarcoma, NOS 
Leiomyosarcoma, NOS 
Connective, 
subcutaneous 
Connective, 
subcutaneous 
Mandible 
Connective, 
subcutaneous 
IIB 
 
IIA 
 
 
IIA 
III 
II 
 
II 
 
 
II 
III 
F 
 
F 
 
 
F 
F 
42 
 
65 
 
 
36 
59 
NW 
 
W 
 
 
W 
W 
Neurofibrosarcoma       
Malignant peripheral nerve sheath 
tumor 
Peripheral nerves and 
autonomic 
IA I M 44 W 
Nevi & Melanomas       
Malignant Melanoma Partotid gland NA NA M 61 W 
Nonencapsul. Sclerosing Ca.       
Nonencapsulating sclerosing 
carcinoma 
Thyroid gland I I F 19 W 
Oligodendroglioma, NOS       
Oligodendroglioma, NOS 
Oligodendroglioma, anaplastic 
Frontal Lobe 
Frontal Lobe 
NA 
NA 
NA 
NA 
F 
M 
46 
33 
W 
W 
Osteosarcoma, NOS       
Osteosarcoma, NOS 
 
Chondroblastic osteosarcoma 
Bones of skull and 
face 
Vertebral column 
IA 
 
IVB 
I 
 
IV 
M 
 
M 
84 
 
19 
NW 
 
W 
Other Leukemias       
Hairy cell leukemia 
Hairy cell leukemia 
Bone marrow 
Bone marrow 
NA 
NA 
NA 
NA 
M 
M 
77 
41 
W 
W 
Other Myeloid Leukemias       
Chronic myelogenous leukemia, 
BCR/ABL pos 
Chronic myelogenous leukemia, 
BCR/ABL, pos 
Bone marrow 
 
Bone marrow 
 
NA 
 
NA 
NA 
 
NA 
F 
 
F 
77 
 
56 
NW 
 
W 
Other Spec. Non-Hodgkin 
Lymphoma 
      
NK/T-cell lymphoma, nasal and 
nasal type 
Anaplastic large cell lymphoma, 
T-cell and  
Nasal cavity 
 
Ethmoid sinus 
IEA 
 
IVA 
I 
 
IV 
F 
 
F 
64 
 
86 
W 
 
W 
Oxyphilic Adenocarcinoma       
Oxyphilic adenocarcinoma Thyroid gland II II F 56 NW 
Paget Disease, Extramammary       
Paget disease, extramammary 
Paget disease, extramammary 
Skin of trunk 
Skin of trunk 
Unk 
II 
Unk 
II 
M 
M 
59 
65 
W 
W 
Papillary & Follicular Adenoca.       
Mixed medullary-papillary 
carcinoma 
Thyroid Gland IVA IV M 79 W 
Papillary Carcinoma, NOS       
Verrucous carcinoma, NOS 
 
Papillary squamous cell 
carcinoma 
Ventral surface of 
tongue 
Pharynx, NOS 
I 
 
NA 
I 
 
NA 
F 
 
M 
69 
 
36 
W 
 
W 
Papillary Cystadenoca., NOS       
Intraductal papillary-mucinous 
carcinoma 
Head of pancreas IA I F 64 NW 
Phylllodes Tumor, Mal.       
Phyllodes tumor, malignant Breast, NOS IIA II F 91 NW 
Polycythemia Vera       
Polycythemia vera Bone marrow NA NA M 69 W 
Prolymph/Precurs Leukemia       
Prolymphocytic leukemia, T-cell 
type 
Bone marrow 
 
Bone marrow 
NA 
 
NA 
NA 
 
NA 
M 
 
M 
68 
 
59 
W 
 
NW 
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Prolymphocytic leukemia, T-cell 
type 
Refractory Anemia       
Refractory anemia with excess 
blasts 
Refractory anemia with excess 
blasts  
Refractory anemia with excess 
blasts 
Bone marrow 
 
Bone marrow 
 
Bone marrow 
NA 
 
NA 
 
NA 
NA 
 
NA 
 
NA 
 
F 
 
F 
 
M 
58 
 
59 
 
78 
W 
 
NW 
 
NW 
Sarcoma, NOS       
Giant cell sarcoma Connective, 
subcutaneous 
III III F 68 NW 
Squamous Cell Carcinoma       
Sq. cell carcinoma, keratinizing, 
NOS 
Sq. cell carcinoma, keratinizing, 
NOS 
Sq. cell carcinoma, keratinizing, 
NOS 
Sq. cell carcinoma, keratinizing 
NOS 
Sq. cell carcinoma, spindle cell 
Sq. cell carcinoma spindle cell 
Sq. cell carcinoma, lg. cell, non-
ker 
Vulva 
 
Overlapping lesion 
nasopl 
Ovary 
 
Vulva, NOS 
 
Vagina 
Glottis 
Nasopharynx, NOS 
IVA 
 
III 
 
IIB 
 
IB 
 
III 
I 
III 
IV 
 
III 
 
II 
 
I 
 
III 
I 
III 
F 
 
F 
 
F 
 
F 
 
F 
M 
M 
53 
 
41 
 
55 
 
49 
 
63 
74 
23 
W 
 
W 
 
NW 
 
W 
 
NW 
W 
W 
Stromal Sarcoma       
Adenosarcoma Endometrium IA I F 58 W 
Sweat Gland Adenocarcinoma       
Apocrine adenocarcinoma Upper outer quadrant 
of bre 
IA I F 58 NW 
Thymoma, Malignant       
Thymic carcinoma, NOS Thymus NA NA F 73 W 
 
Table 15: Histology group descriptions by gender and race 
Histology Group Description 
54 Types of Rare Cancers 
Gender 
 
Race 
 
 Male Female White Non-
White 
Acinar Cell Carcinoma 0 1 0 1 
Adenocarcinoma with Metaplasia 0 2 1 1 
Adenocarcinoma, NOS 1 2 3 0 
Adenoid Cystic & Cribriform CA. 0 2 1 1 
Astrocytoma, NOS 1 1 1 1 
Carcinoid Tumor, Malignant 3 9 7 5 
Carcinoma, NOS 1 0 1 0 
Carcinoma, Undiff., NOS 1 0 1 0 
Carcinosarcoma, NOS 0 1 0 1 
Cholangiocarcinoma 2 0 2 0 
Chronic Myeloproflierative Dis. 1 2 2 1 
Clear Cell Adenocrcinoma, NOS 1 2 3 0 
Cystadenocarcinoma, NOS 0 1 1 0 
Endometrioid Adenocarcinoma 0 2 1 1 
Erythroid Leukemia 0 1 1 0 
Ewing Sarcoma 2 0 1 1 
Fibromatous Neoplasms 4 2 5 1 
Fibrous Histiocytoma, Mal. 0 2 0 2 
Follic. & Marginal Lymh, NOS 2 0 2 0 
Glioblastoma, NOS 5 0 4 1 
Hemangioendothelioma 0 1 1 0 
Immunoproliferative Diseases 1 0 1 0 
Kaposi Sarcoma 1 0 0 1 
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Liposarcoma Neoplasms 0 1 1 0 
Lymphoepithelial Carcinoma 2 0 2 0 
Malignant Lymphoma, NOS 0 1 0 1 
ML, Large B-Cell, Diffuse 2 2 2 2 
ML, Small B-Cell Lymphocytic 1 1 2 0 
Mucinous Adenocarcinoma 1 0 1 0 
Mucoepidermoid Carcinoma 0 1 1 0 
Myeloid Leukemia, NOS 2 0 2 0 
Myomatous Neoplasms 0 4 3 1 
Neurofibrosarcoma 1 0 1 0 
Nevi & Melanomas 1 0 1 0 
Nonencapsul. Sclerosing Ca. 0 1 1 0 
Oligodendroglioma, NOS 1 1 2 0 
Osteosarcoma, NOS 2 0 1 1 
Other Leukemias 2 0 2 0 
Other Myeloid Leukemias 0 2 1 1 
Other Spec. Non-Hodgkin 
Lymphoma 
0 2 2 0 
Oxyphilic Adenocarcinoma 0 1 0 1 
Paget Disease, Extramammary 2 0 2 0 
Papillary & Follicular Adenoca. 1 0 1 0 
Papillary Carcinoma, NOS 1 1 2 0 
Papillary Cystadenoca., NOS 0 1 0 1 
Phylllodes Tumor, Mal. 0 1 0 1 
Polycythemia Vera 1 0 1 0 
Prolymph/Precurs Leukemia 2 0 1 1 
Refractory Anemia 1 2 1 2 
Sarcoma, NOS 0 1 0 1 
Squamous Cell Carcinoma 2 5 5 2 
Stromal Sarcoma 0 1 1 0 
Sweat Gland Adenocarcinoma 0 1 0 1 
Thymoma, Malignant 0 1 1 0 
TOTAL: 51 62 79 34 
 
